Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Current developments and future perspectives on the formation of luminescent lanthanide supramolecular self-assembly architectures with a focus on nitrogen-based donor ligands

Sandra Fernández-Fariña ab, Oxana Kotova ac, Shauna R. Donohoe a and Thorfinnur Gunnlaugsson *ac
aSchool of Chemistry and Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin, The University of Dublin, Dublin 2, Ireland. E-mail: gunnlaut@tcd.ie
bDepartamento de Química Inorgánica, Facultade de Química, Campus Vida, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
cSynthesis and Solid-State Pharmaceutical Centre (SSPC), School of Chemistry, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland

Received 30th June 2025

First published on 21st October 2025


Abstract

Research on luminescent lanthanide (Ln) self-assembly structures has emerged into a discrete field with clear evolution from monometallic to polymetallic systems over the last few decades. The interest in these assemblies stems, on the one hand, from their structural diversity and fascinating complexity, while on the other hand, from the unique luminescence properties of the lanthanide ions, allowing for the expansion of their applications from materials science to mimicking biological systems. This review begins with a description of the recent advances in the design and properties of monometallic Ln3+ self-assemblies, with a particular focus on tridentate motifs, such as dpa, pybox, and btp, and other non-tridentate nitrogen donor ligands. Later, polymetallic systems, including helicates and metallocages, are described with their structures, followed by an elaboration on how a careful ligand design allows for the modification of the overall assembly (i.e. helical, tetrahedral, cubic and other polyhedra). The influences of counter-anions, concentrations, metal:ligand ratios and solvents are also discussed. The fascinating new developments within mechanically interlocked molecules containing lanthanide ions are highlighted with a focus on their structural complexity and reversible binding properties. Furthermore, this review will focus on the functional properties of lanthanide assemblies including their temperature-dependent luminescence, host–guest interaction and aggregation-induced emission. The use of such ligands in metallo-supramolecular polymers is briefly discussed, including their application in the generation of luminescent hydrogels, supramolecular polymers and other conventional polymers. We conclude this review with the perspective of exploring the biological properties and toxicity of lanthanide complexes, their application in imaging, and the recovery of lanthanides for sustainable use as well as their promising applications in smart materials, sensing and diagnostics.


image file: d5cs00750j-p1.tif

Sandra Fernández-Fariña

Sandra Fernández Fariña completed her PhD in 2021 at Universidade de Santiago de Compostela under the supervision of Prof. Rosa Pedrido and Prof. Ana M. González Noya, working on metallosupramolecular chemistry. She then joined the molecular spectroscopy service at Universidade da Coruña as a “Programa Investigo” beneficiary (2022-2023). Later, she moved to the School of Pharmacy at Universidad Complutense de Madrid under the supervision of Dr Marco Filice, studying the antibacterial properties of bioactive compounds. In 2024, she became a Postdoctoral Fellow at Universidade do Porto, focusing on porphyrin-derived photosensitisers for photodynamic therapy. Since October 2024, she has been a Xunta de Galicia postdoctoral fellow in the group of Thorri Gunnlaugsson, exploring functional self-assembly architectures for different applications, and she will soon be joining the research group of Prof. David A. Leigh where she will continue her Xunta de Galicia postdoctoral fellowship at the University of Manchester.

image file: d5cs00750j-p2.tif

Oxana Kotova

Oxana Kotova is a Senior Research Fellow in the group of Prof. T. Gunnlaugsson at the School of Chemistry, Trinity College Dublin, Ireland. Oxana graduated with a Master's degree in Chemistry and Materials Science and completed her PhD in Inorganic Chemistry from Lomonosov Moscow State University (MSU), working on luminescent lanthanide complexes as electroluminescent materials for organic light-emitting diodes under the supervision of Prof. Natalia Kuzmina and Prof. Leonid Lepnev. After completing her PhD Oxana worked on a collaborative project between MSU and Lebedev Physical Institute. She was then supported by the Irish Research Council Grant to continue her research in Ireland. Her current research focuses on lanthanide-based supramolecular assemblies, including chiral systems for imaging and sensing applications. More recently, she worked on the development of MOFs for industrial solvent purification.

image file: d5cs00750j-p3.tif

Shauna R. Donohoe

Shauna R. Donohoe received her PhD from Trinity College Dublin in 2025. During this time, she studied the self-assembly of novel triazole-pyridine derivatives with lanthanide ions, investigating their luminescence properties. She subsequently began working for Senator Annie Hoey at Houses of the Oireachtas, mainly undertaking policy research related to further & higher education in Ireland. She is currently completing a Postgraduate Diploma in Medical Device Technology & Business at Griffith College Dublin, in collaboration with Innopharma Education.

image file: d5cs00750j-p4.tif

Thorfinnur Gunnlaugsson

Professor Thorfinnur (Thorri) Gunnlaugsson MRIA holds a Personal Chair in the School of Chemistry at Trinity College Dublin, being appointed in 1998. He has supervised over 60 PhD students and a large number of postdoctoral fellows since then. He is the author of over 300 publications, and in 2022, he co-edited “Supramolecular Chemistry in Biomedical Imaging”, Monographs in Supramolecular Chemistry No 33 (published by RSC) with Prof. Stephen Faulkner and Dr Gearóid M. Ó Máille. His work has been recognised with various awards including the Institute of Chemistry (ICI) of Ireland Brown Award in 2023 and the MSMLG Czarnik Award in 2021. He was elected as a Member of the Royal Irish Academy (MRIA) in 2011 and is a fellow of both the ICI and the RSC.


1. Introduction

Over the past five decades, supramolecular chemistry1 has progressed into a highly sophisticated and multidimensional field, leading to diverse functional self-assembled architectures. The developments in this field1 have been recognised by two Nobel Prizes: in 1987, awarded to Pedersen,2 Cram3 and Lehn1 for their fundamental work on crown ethers, carcerands and cryptands; and later in 2016, to Sauvage,4 Stoddart5 and Feringa6 for their pioneering contributions to the understanding of molecular machines. These advances continue to expand the scope of supramolecular chemistry, driving the development of novel molecular systems with broad real-world applications in nanotechnology, materials science, or biomedicine. Within this field, metallosupramolecular chemistry stands out owing to its distinct advantages over alternative self-assembly strategies based on non-covalent interactions such as hydrogen bonding, hydrophobic effects or van der Waals forces. In contrast, metal-ligand coordination enables the construction of robust and well-defined supramolecular architectures arising from the coordination preferences and geometrical constraints of both d- and f-block metal ions, such as the lanthanides, Ln3+.7,8 The resulting supramolecular structures not only reflect the geometric arrangement determined by the metal ions but can also incorporate the unique physical properties of the metal ion centre itself.9 In general, for the formation of self-assembly systems, the careful design of the ligands is crucial to determine the stability and architecture/structure of the self-assemblies as they must satisfy the coordination requirements of the chosen metal ions.10 This is also critical for outlining the rationale for the application of the resulting assembly.

Recent progresses within the field of d- and f-metal ions have led to the design and precise control of complex supramolecular architectures including but not limited to helicates,7,11–13 metallocages,14,15 metal–organic frameworks (MOFs),16–19 and mechanically interlocked molecules (MIMs) such as catenanes,20,21 rotaxanes21–23 and knots.24–27 These architectures are inherently dynamic, making them ideal candidates for the development of functional and responsive supramolecular architectures governed by external stimuli such as pH, temperature, or solvent polarity.28,29 Moreover, self-assembly strategies have enabled the formation of molecular architectures that are difficult to achieve through traditional synthetic approaches, allowing supramolecular chemists the creative freedom to design such beautiful, complex and functional structures. This has further enhanced our understanding of the living systems, especially when chiral ligands are used in self-assembly processes giving us insights into the origin and transfer of chirality within such assemblies.30 Furthermore, the complexity of self-assemblies can be enhanced through templated synthesis, which is also a powerful approach to achieve MIMs within the metal-directed self-assembly.31–36

The potential applications of the aforementioned self-assembled supramolecular architectures are extensive, including fields such as drug delivery,37,38 optoelectronics,39–41 imaging,42–44 and chemical (chemo-) activity based sensing.45–50 While most of the research in metallosupramolecular chemistry has focused on d-metal ions,51–53 f-metal ions have emerged as promising candidates due to their many unique properties54 and coordination behaviour/requirements.55–57 In particular, the research groups of Horrocks, Bünzli, Piguet and Raymond58 have pioneered the field of Ln3+-directed self-assemblies, having conducted extensive research in this area over the years.59–63 Moreover, chiral lanthanide self-assemblies with emission properties have emerged as promising candidates for developing circularly polarised luminescent (CPL) materials.64 The development of Ln structures with aggregation-induced emission properties (AIE) has also been recently reported, exhibiting aggregation-induced emission along with high glum and BCPL values. This finding paves the way for the development of dynamic chiral luminescent materials, but the complexes were also used as luminescent inks.65

Thus far, many outstanding reviews have been reported covering different aspects of lanthanide chemistry,64,66–78 highlighting their intricate chemistry, which has been widely used in developing responsive and complex supramolecular structures. We also would like to direct the reader's attention to the outstanding work of Prof. Parker research group on the field of responsive lanthanide complexes based on cyclen ligands. These contributions provide essential insights into the design of new functional complexes.79–91

The present review we hope will provide a comprehensive overview of the latest advancements, focusing on the period of 2017 to present, in the field of luminescent lanthanide metallosupramolecular architectures derived from non-macrocyclic, primarily nitrogen-based donor ligands, with a particular focus on the ligand design, their photophysical properties (and that of the assembly), and their applications as functional materials. Within this manuscript we will not be discussing the mechanism of the lanthanide sensitisation, and instead we would like to refer readers to some of the excellent reviews covering such topics.8,55,92–96

It has to be noted that research on further understanding of the mechanisms of lanthanide luminescence is ongoing, and includes, but not limited to, studies on the mechanism and pathways of energy transfer processes through the antennae (sensitisation) effect,97–100 the determination of the lanthanide coordination geometry through a range of luminescence measurements, and theoretical/computational analysis,101–108 as well as point group assignment,109 as well as studies on lanthanide luminescence quenching pathways,110 determination of triplet-state energy behaviours,111 and creating a method to bypass luminescence quantum yield determination,112 the effect of chirality, etc. The studies of excited-state dynamics and revisiting Horrocks method,113 as well as development of new theoretical tools to practice Judd–Ofelt theory are also currently under investigations in various laboratories.114,115

The outline of our review is depicted in Scheme 1. The first section of our contribution will discuss the recent advances in the formation of monometallic Ln3+-derived self-assemblies, while the following section will discuss new developments in polymetallic Ln3+-derived self-assemblies such as helicates, metallocages and mechanically interlocked molecules (MIMs); an area that has relatively recently emerged within lanthanide chemistry. The role of metallo-supramolecular polymers will also be briefly explored in this context.76 Given that the extensive work on lanthanide-based coordination polymers and MOF chemistry has been recently reviewed, this topic will not be covered in the present work, and we would like to refer readers to the following references.17,19,116–118


image file: d5cs00750j-s1.tif
Scheme 1 Main topics discussed in this review.

2. Recent advances in monometallic Ln3+-derived self-assemblies

A considerable number of mononuclear ligands have been designed for Ln3+ assemblies over the years. In particular, the tridentate binding unit is one of the most attractive motifs, as it can readily fulfil the Ln3+ coordination requirements by binding in a 1/3 (metal/ligand) ratio to form stable tris complexes. The self-assembly processes involving tridentate ligands have been the subject of extensive research, with a particular focus on pyridine-centred ligands75,119 such as pyridine-2,6-dicarboxylic acid (H2dpa),108,120,121 pyridine-bis(oxazoline) (pybox),122 2,6-bis(1,2,3-triazol-4-yl)pyridine (btp),77,123 2,6-di(pyrazolyl)pyridine (bpp)124 and 2,2′:6,2′′-terpyridine (terpy).120,125 In this review, we will present different examples of Ln3+-derived self-assemblies from ligands containing these tridentate motifs, emphasising the properties and range of applications of the resulting structures and self-assemblies.

2.1. Lanthanide self-assemblies based on a H2dpa motif

Lanthanide self-assemblies derived from dpa cores or binding units have attracted significant attention in recent years.79 The dpa motif facilitates the formation of stable tris Ln3+ complexes with high binding constants and excellent luminescent quantum yields that exist as Δ- and Λ-[Ln(dpa)3]3− enantiomers (Fig. 1).126–128 Additionally, it can be easily modified via amide coupling reactions, as well as modification on the pyridine unit itself, which explains why the dpa motif is now used widespread in contemporary lanthanide-based supramolecular assembly formation.
image file: d5cs00750j-f1.tif
Fig. 1 Structural formulas of Δ-[Ln(dpa)3]3− and Λ-[Ln(dpa)3]3− enantiomers.127 Reproduced from ref. 127 with permission from the Royal Society of Chemistry, Copyright©2012.

Recently, Sørensen and co-workers have further investigated the coordination chemistry of dpa ligands using a range of lanthanide ions. For example, they explored the luminescence properties of two dpa-derived Eu3+ complexes synthesised with the same reagents but varying the pH of the media during crystallisation. Under acidic conditions, the [Eu(dpa)(Hdpa)(H2O)2]·4H2O complex was found to be the predominant species, while in basic media the Na3[Eu(dpa)3]·14H2O complex dominated. They found that the lower symmetry on Na3[Eu(dpa)3]·14H2O resulted in a more complex emission spectrum, thus being an example of pH-dependent luminescence behaviour.121 Similarly, they observed the same behaviour for Sm3+ dpa-derived complexes.108 These complexes again exhibit pH-dependent colour changes where their luminescence was reversibly affected by pH, opening a possibility for pH sensing applications. A similar pH-dependent behaviour had previously been demonstrated for tetra-substituted 1,4,7,10-tetraazacylcododecane (cyclen)-based Eu-complexes by Gunnlaugsson.129 Following this line, a range of lanthanide complexes (Ln = Eu3+, Tb3+ and Dy3+) with H2dpa have been obtained through a hydrothermal method, again showing pH-dependent emissions.130

These complexes were also explored for other applications. For example, the effect of the incorporation of the [Eu(dpa)3]3− complex into a mesoporous silica matrix through incipient wetness impregnation was explored and the photophysical properties probed. Their results indicate that this finding enhances the luminescence properties of the materials, being an important approach for the development of advanced luminescent materials.131,132

Over the years, the Gunnlaugsson group (as well as the Leigh group, see discussion later) has done extensive research on Ln(III)-directed self-assemblies using the dpa moiety, in combination with chiral naphthalene arms.133–135 The developed ligands showed effective sensitisation of lanthanide emission,136,137 and as mentioned before, the presence of the chiral centres within the organic ligands allowed for the transfer of chirality to Ln3+ centres, leading to well-resolved CPL emissions with ‘good’ luminescence dissymmetry factors (glum).127,138–141

Recently, Taniguchi et al. have shown that Tb3+ complexes synthesised from these chiral naphthalene-derived ligands also showed strong magnetochiral dichroism.142 Gunnlaugsson's research group then also demonstrated the use of circular dichroism (CD) and CPL spectroscopy to confirm the chirality of luminescent monometallic Ln3+ complexes derived from ‘half helicate’ ligands.133,135 The result allowed the identification of different binding stoichiometries and binding affinities and, importantly, enabled the determination of the unique (chiral) CD fingerprint for each of these stoichiometries.133,135

While previous studies focused primarily on the fundamental behaviour of Ln3+ self-assembly systems in solution, our group has extended this work towards the development of Ln3+-directed self-assemblies as functional materials. Recent examples include the use of previously reported dpa-based naphthalene-derived chiral ligands.134,143,144 Further modifications to the aforementioned ‘half-helicate’ ligand, by simply incorporating long alkyl chains at the free carboxylic acid side, were designed to enhance its material properties with the aim of forming Langmuir–Blodgett monolayers. Particularly, the Eu3+ complexes were the first examples of amphiphilic self-assembles exhibiting Eu(III)-centred CPL.143 More recently, the authors developed luminescent Langmuir–Blodgett (LB) films containing discrete Ln(1)3 chiral amphiphilic complexes (Ln3+ = Sm3+, Tb3+, Dy3+ and Lu3+) derived from ligand 1 (Fig. 2).145


image file: d5cs00750j-f2.tif
Fig. 2 Chiral dpa asymmetrical ‘half-helicate’ ligands with long chains 1(R) and 1(S).145 Reproduced from ref. 145 with permission from the Royal Society of Chemistry, Copyright©2012.

The effect of immobilisation of these complexes into LB films on their luminescence properties was also investigated. Although Ln3+-centred luminescence was observed along with CPL in the solution for all the complexes, unfortunately, no CPL emission could be detected from single-monolayer LB films of the Tb(1)3 and Sm(1)3 systems, possibly due to low concentration effects.145 With the aim of overcoming this challenge, the authors are working on improving the current system.

Recently, Kitchen and co-workers reported the synthesis and study of lanthanide amphiphiles using 2(R) and 2(S) ligands (Fig. 3), where Ln3+ = La3+, Sm3+, Eu3+, Tb3+ and Dy3+.146 They incorporated complexes of Eu3+, Tb3+, Dy3+ and Sm3+ in a 1/1/10/50 ratio to create quadruple-emitting thin films. This study opens the door for their use in a range of sensing applications, as four distinct receptors for sensing can be functionalised to each respective Ln3+ complex within the films.


image file: d5cs00750j-f3.tif
Fig. 3 Asymmetrical carboxylate dpa ‘half-helicate’ ligands with long chains 2(R) and 2(S) and lanthanide complexes under UV light (λex = 254 nm): left to right Sm(2)3, Dy(2)3, Tb(2)3 and Eu(2)3.146 Adapted from ref. 146 with permission from the Royal Society of Chemistry, Copyright©2021 (CC BY 3.0).

Kitchen et al. also reported the synthesis of the asymmetric ligand 3 (Fig. 4), a dpa-based ligand that has been functionalised with the 1,8-naphthalimide chromophore (Nap).147 It was found that the resulting Eu3+ complex, Eu(3)3, was multi-emissive, displaying colour-tuneable emission windows by changing the excitation wavelength in both the solid and solution states; the phenomenon arising from the mixing of the blue-centred emission of 1,8-naphthalimide and the Eu(III)-centred red emission. The complex retained these photophysical properties when spin-coated onto quartz slides, yielding thin films that were further analysed.147 Researchers in the Kitchen group are currently investigating the potential of the application of these systems for use in self-calibrating ratiometric oxygen sensors.


image file: d5cs00750j-f4.tif
Fig. 4 (A) Eu(3)3 solutions depicted under a UV light (λex = 254 nm) at different concentrations (10, 5, 1, and 0.01 mM from left to right) in MeOH. (B) Fluorescence emission spectra of Eu(3)3 at different excitation wavelengths showing different intensities of Eu3+-centred emission versus Nap emission.147 Adapted from ref. 147 with permission from the Royal Society of Chemistry, Copyright©2023.

Besides modifying the ‘arms’ of these monotopic systems, many research groups have explored variations at the para-position of the central pyridyl ring to introduce a functionality. Gunnlaugsson, in collaboration with Pal and co-workers, has recently expanded on their designs and developed various dpa-based ligands (4a–d) with different functionalities at the back of the pyridine unit via an ether linkage. These, as evidenced before,148 have been shown to enhance solubility in competitive solvents, such as alcohols (Fig. 5).149


image file: d5cs00750j-f5.tif
Fig. 5 Chiral ligands 4(R,R)/(S,S) that possess different functionalities at the 4-position of the pyridine ring (4a–d); corresponding crystal structures of the Eu3+ complexes Eu(4c)3 formed from the (S,S) and the (R,R) enantiomers of the propargyl derivative 4c.149 Adapted from ref. 149 with permission from the Royal Society of Chemistry, Copyright©2024.

The crystal structures of Eu3+ complexes with these chiral ligands have been resolved, as demonstrated in Fig. 5 for the complexes formed from the (R,R) and (S,S) ligands of 4c, which give rise to the formation of either Λ for Eu(4c(R,R))3 or Δ stereochemistry around the Eu3+ centre within such complexes. The packing of the complexes within the structure also demonstrated that the helical nature of the complexes was extended into the three dimensions for both systems. The chiral nature of the complexes in the solid state was also confirmed by recording the CPL emission from both systems in their solid state using conventional CPL spectroscopy and the newly developed CPL laser scanning confocal microscopy (CPL-LSCM). The latter method opens a new and unexplored means of probing chirality of such lanthanide complexes in the solid state, in addition to conventional solution state studies.149

In related studies, Signore et al.150 reported the H2dpa derivative ligands, 5 and 6, which were functionalised with coumarin at the 4-pyridyl position (Fig. 6). The addition of iodine in compound 6 resulted in the appearance of a second absorption shoulder at ca. 375 nm, which, in theory, should enhance the luminescence of the resulting tris Eu3+ complexes. However, negligible differences in the quantum yield were observed between Eu(5)3 and Eu(6)3, with both complexes displaying low quantum yields, suggesting that the presence of other non-radiative pathways were responsible for the quenching of the lanthanide luminescence. These results show that the introduction of iodine (via the heavy atom effect) is not enough (alone) to enhance the luminescence of the complexes in this instance.


image file: d5cs00750j-f6.tif
Fig. 6 (A) H2dpa derivatives functionalised with coumarin at the 4-pyridine position (5, 6),150 chiral ligand based on the dpa motif functionalised at the 4-pyridine position (7).151 (B) Absorption (green) and excitation (blue, λem = 615 nm) spectra normalised at 365 nm and emission (red, λexc = 365 nm) spectra of [Eu(7)3]3+ complexes (c = 16 × 10−6 M) in acetonitrile. (C) X-ray structure of the Λ-[Eu(R-7)3]Cl3 complex.151 Adapted from ref. 151 with permission from the Royal Society of Chemistry, Copyright©2019.

In another study, Pal and colleagues reported the use of the related chiral ligands 7(R,R) and 7(S,S) (Fig. 6).151 The resulting Eu(III) enantiomeric complexes, Eu(7(R,R))3Cl3 and Eu(7(S,S))3Cl3, demonstrated stability in solutions over a period of several months, with no alterations to glum values. The aforementioned glum value quantifies the degree of circular polarization in the emitted light, and is a key parameter in CPL studies. The authors reported that the stability of these values indicates that the chiral environment around the Eu3+ centre remains unchanged over time (i.e. no racemisation). Consequently, this property rendered Eu(7)3Cl3 as an ideal candidate for use as a standard reference in the calibration of CPL spectrometers.

The interest to the development of the ligand's derivatives of H2dpa for their coordination to the Ln ions has been ongoing, and recently, de Bettencourt-Dias and colleagues have carried out extensive research on luminescent lanthanide complexes derived from this motif centred on their potential biological properties/applications. Particularly, some of their research studies have focused on luminescent lanthanide complexes capable of generating cytotoxic single oxygen (1O2). This interest stems from their potential therapeutic applications such as MRI contrast agents, among others, due to their selective accumulation in tumour tissues. They developed dpa-derived ligands functionalized with a 1,8-napthalamide moiety, 8 and 9 (Fig. 7) and their corresponding Nd3+, Eu3+ and Yb3+ complexes Ln(8)3 and Ln(9)3, which showed the capability of generating 1O2 with high efficiency.152


image file: d5cs00750j-f7.tif
Fig. 7 (A) Derivatives of H2dpa ligand functionalized with 1,8-napthalamide (8, 9). (B) Normalized emission spectra of the [Ln(9)3]3+ complexes [Ln = Eu3+ (blue), Nd3+ (light blue), or Yb3+ (navy)].152 Adapted from ref. 152 with permission from the American Chemical Society, Copyright©2019.

Later, the de Bettencourt-Dias group has studied ligand 10 (Fig. 8) and its complexes Nd(10)2, Er(10)2 and Yb(10)2. These were the first examples to show the ability to control 1O2 generation through the excitation wavelength attributed to the presence of multiple sensitisation pathways from 10 to the Ln3+ ions due to the presence of 2,2′:5′,2′′-terthiophene within the ligand.153 Following the same ligand design, ligand 11 (Fig. 8) was found to be capable of sensitising Ln3+ ions (Ln = Nd3+, Eu3+, Gd3+, Er3+ and Yb3+), also leading to the excitation wavelength-dependent 1O2 generation in Ln(11)2 complexes.154 However, all these complexes were found to be insoluble in water, which renders them useful for therapeutic applications, but providing a new route for the formation of this type of systems.


image file: d5cs00750j-f8.tif
Fig. 8 Ligands (10–13) synthesised by de Bettencourt-Dias and coworkers.153–155

Recently, the same group has reported ligands 12 and 13 (Fig. 8), and their respective Ln(12)3 and Ln(13)3 complexes where Ln = Eu3+, Gd3+ and Yb3+. These complexes displayed improved water solubility and luminescence properties, and excitation wavelength-dependent 1O2 generation was also observed, which is more efficient for the complexes with ligand 13. Moreover, all the compounds showed interesting photocytotoxic activity against HeLa cells making them attractive for application in photodynamic therapy.155

The research group of de Bettencourt-Dias also reported a dpa-derived ligand functionalised with an amino group at the 4-pyridyl position and their [Ln(L)3], where Ln = La3+, Eu3+, Gd3+, and Tb3+, showing luminescence and stability under physiological pH conditions. The cytotoxicity of these complexes was also studied against different tumour cells showing high values of cytotoxic activity. The authors highlight the strong red luminescence of [Eu(L)3] and its ability to penetrate cancer cells, which is effective for use as luminescent dye. This complex was also able to cross a simulated blood–brain barrier, and hence, it is a potential theragnostic agent.156

De Bettencourt-Dias's group has also developed lanthanide complexes derived from dpa ligands possessing carbazole groups. In these studies, they found that both the Eu(L)3 and the Yb(L)3 complexes display viscosity-dependent emission under both one-photon and two-photon excitation. Moreover, the Yb(L)3 complex is the second example reported of viscosity sensing based on the NIR-emitting Ln3+ compound.157 They expanded this study by performing the synthesis of a new dpa ligand functionalized with carbazole and its Eu(L)3 and Yb(L)3 complexes, finding a viscosity- and temperature-dependent behaviour.158 These results highlight carbazole-functionalized dpa ligands as promising in the fields of imaging, sensing, and diagnosis.

In line with the potential biological applications of dpa-derived lanthanide complexes, Byrne and colleagues reported the synthesis of terbium complexes derived from different glycoconjugate ligands.159 These systems showed enhancement of terbium-centred emissions in solutions in the presence of carbohydrate-binding protein LecA, a lectin associated with Pseudomonas aeruginosa, a Gram-negative bacterium responsible for numerous infections. This sensing ability was also demonstrated in the presence of competitors, opening a path to develop more complexes with this characteristic for use as a diagnostic tool.

Lately, Daumann and coworkers studied the influence of the presence of lanthanide ions on the activity of methanol dehydrogenases (MDH), crucial enzymes in both microbial metabolism and environmental applications.160,161 The enzyme activity was monitored using two different assays: dye-coupled and protein-coupled assays. The results displayed that the MDH activity was higher in the presence of La3+, Ce3+ and Pr3+, demonstrating the importance of lanthanides in enhancing the MDH enzyme activity.160

2.2. Lanthanide self-assemblies derived from pybox

Another class of ligands that have been extensively used in Ln(III)-directed self-assemblies over the years are pybox motifs.162,163 Often pybox-derived ligands have been used in combination with β-diketonates to form stable Ln3+ complexes. Lanthanide β-diketonates are a widely studied class of complexes because many of these ligands are commercially available and their corresponding complexes are highly luminescent.164–169

Di Bari's group has carried out intensive research with lanthanide complexes derived from the pybox motif. For example, they reported the formation of Ln3+ complexes (Ln3+ = Eu3+ or Tb3+) using 14(R,R), 14(S,S), 15(R,R) or 15(S,S) (Fig. 9) and studied their luminescent and chiroptical properties.122


image file: d5cs00750j-f9.tif
Fig. 9 Structural formulas of β-diketones hexafluoroacetylacetone (Hhfa), 2-thenoyltrifluoroacetone (H2Htta) and pyridine bis-oxazoline (pybox)-derived chiral ligands 14–16.122,170

Their studies have shown that the stoichiometry of these Ln complexes was influenced by the substituents of the pybox oxazoline ring, with 15 forming the typical tris complexes with Ln3+, whereas 14 preferred a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 (L[thin space (1/6-em)]:[thin space (1/6-em)]M) stoichiometry where the coordination environment of the Ln ion is not fully saturated, giving the possibility of ancillary ligand coordination, leading to the potential application of these complexes as a ‘probe’ for the detection of chiral analytes or as an emissive layer in organic light-emitting devices (OLEDs). This study also demonstrates the importance of the ligand design and how it then influences the corresponding lanthanide complexes.122

Di Bari's research group also reported a series of Ln(hfa)3(L) and Ln(tta)3(L) complexes (Ln3+ = La3+, Sm3+, Eu3+, Gd3+, Tm3+ and Yb3+) synthesized combining the chiral H2pybox derivatives 14(R,R), 14(S,S), 15(R,R) or 15(S,S) with the achiral β-diketones such as hexafluoroacetylacetone (Hhfa) or 2-thenoyltrifluoroacetone (Htta) (Fig. 9).171 The resulting complexes exhibited strong CPL emissions. Using chiroptical, CD, CPL and vibrational CD spectroscopy, and a range of optical measurements, a ‘super-spectrum’ was elucidated by the authors, indicating that all the complexes shared a homogeneous structural environment. Additionally, in this study, vibrational circular dichroism (VCD) was highlighted as an alternative and promising method for probing the structures of the lanthanide complexes in solutions. These findings contribute to the advancement of characterisation and design of functional lanthanide-based (chiral) materials.171 Lately, the authors have further explored the properties of the reported Yb(hfa)3(L) and Yb(tta)3(L) complexes also derived from 14(R,R), 14(S,S), 15(R,R) and 15(S,S). These complexes were found to exhibit a NIR-CPL emission, a phenomenon that is only recently beginning to be suited for such lanthanide systmes.172 This was followed up by the incorporation of a conjugated substituent through the pyridine 4-position of 15, resulting in ligand 16 (Fig. 9). Upon coordination with Er3+, the Er(16)2 complex was obtained.127 This complex exhibited efficient NIR-CPL emission in the 1400–1600 nm region, achieved by the extended π-conjugation of the ligand system, known to sensitise the low-energy Er3+ levels.170 These findings highlight their potential for applications in NIR-CPL bioassays or chiral NIR optoelectronics.

Yuasa et al. reported complexes of Eu3+ with asymmetric chiral pybox ligands 17(R) or 17(S) combined with three chelating units of β-diketonate hfa, as shown in Fig. 10.173 The resulting Eu(17(R))(hfa)3 complex was observed to switch CPL handedness upon binding of a trifluoroacetic anion (CF3COO). Furthermore, the CPL emission for Eu(17(R))(hfa)3 was unaffected in the presence of competing anions, making the complex a ‘target-identifiable probe’.


image file: d5cs00750j-f10.tif
Fig. 10 Schematic of the CF3COO anion coordinated to Eu(R-17)(hfa)3, resulting in a switch in the CPL handedness. Adapted from ref. 173 with permission from the American Chemical Society, Copyright©2022 (CC BY 4.0).173

More recently, de Bettencourt-Dias and co-workers have reported two different and efficient lanthanide ion sensitizers derived from the para-substituted pybox motif, 18 and 19, Fig. 11. The complexes derived from these ligands result in high quantum yields of emission in the case of Eu(18)(NO3)3, Tb(18)(NO3)3, and Eu(19)(NO3)3, but showed a lack of sensitisation for the Tb3+ ion, in the case of ligand 19 due to its low triplet state energy level. This study emphasises how the photophysical properties of luminescent Ln3+ complexes can be enhanced by carefully tuning the substituents on the ligand.174


image file: d5cs00750j-f11.tif
Fig. 11 (A) Structural formulas of pybox-derived ligands 18 and 19. (B) Single crystal structure of Eu(19)(NO3)3·H2O.174 Adapted from ref. 174 with permission from the Royal Society of Chemistry, Copyright©2020.

Miao et al. prepared a series of mononuclear lanthanide-derived complexes, Ln3+ (Ln3+ = La3+, Gd3+, and Tb3+).134 They reported the first example of CPL-active Tb3+ complexes containing three coumarin-derived ligands along with the pybox-derived chiral ligand, 20(R,R) or 20(S,S) (Fig. 12). The resulting single diastereomer Eu(20)(coum)3 complex demonstrates that the chiral ligands lead to the formation of a unique structure, enhancing the luminescence properties of Tb3+ enantiomers.175 These findings establish a new pathway for the development of chiroptical organo-Tb3+ luminophores.175 Later, they extended this work by replacing coumarin (coum) ligands with 1-phenyl-3-methyl-4-(isobutyryl)-5-pyrazolone (pmip) as the ancillary ligand, achieving similar results.176


image file: d5cs00750j-f12.tif
Fig. 12 Pybox-derived chiral ligands 20(R,R) and 20(S,S), coumarin (coum) and 1-phenyl-3-methyl-4-(isobutyryl)-5-pyrazolone (pmip) ligands.175,176

2.3. Lanthanide self-assemblies with ligands containing tridentate nitrogen-donor ligands

Another class of binding motifs used to obtain mononuclear complexes involves ligands containing only nitrogen heterocycles for Ln3+ coordination.75,177 Recently, Trifonov and co-workers reported the synthesis of Ln(21)3 complexes (Ln3+ = Eu3+, Gd3+, Tb3+, Dy3+, Er3+ and Yb3+) derived from the monotopic tridentate ligand 21 (Fig. 13).178
image file: d5cs00750j-f13.tif
Fig. 13 Structural formula of ligand 21 (left) and single crystal structure of its dysprosium complex, Dy(21)3(ClO4)3 (right).178 Adapted from ref. 178 with permission from the Royal Society of Chemistry, Copyright©2022.

All the chiral complexes formed exhibited Ln(III)-centred luminescence, except in the case of the erbium(III) complex Er(21)3. In particular, Eu(21)3 and Tb(21)3 exhibited high quantum yields for Eu3+ complex, 57%, and a moderate quantum yield for Tb3+, 17%, in the solid state. Consequently, the researchers investigated whether mixing Eu(21)3 and Tb(21)3 at different ratios in the solid state would have potential temperature-sensing properties. The study revealed that a mixture of Eu(21)3:Tb(21)3 yielded optimal performance as a ratiometric thermometer within the temperature range of 130–220 K, representing one of the first examples of three-blade propeller Ln(III)-compounds designed for luminescence thermometry.178

Avarvari and colleagues have recently designed an enantiopure helicene-based tridentate ligand 22 (Fig. 14), containing an extended π-conjugated system. This ligand leads to the formation of luminescent Eu3+- and Yb3+-derived complexes, Eu(22)(tta)3 and Yb(22)(tta)3. Both complexes exhibit luminescence properties, with the β-diketone tta ancillary ligands completing the coordination sphere. These tta ligands play a crucial role in the antenna effect, sensitizing the luminescence of lanthanide centres. The Eu3+ complex showed typical red luminescence, while the Yb3+ complex exhibited near-infrared emissions. This study highlights the influence of the helicene unit on the chiroptical and luminescence properties of both complexes, demonstrating how structural modifications in the ligand can fine-tune the CPL activity and emission efficiency of lanthanide complexes, and to the best of our knowledge, this is the first example of such CPL system that is not formed on the use of point chirality in the ligand design.179


image file: d5cs00750j-f14.tif
Fig. 14 (A) Structural formula of helicene-derived tridentate ligand 22 synthesised as M and P enantiomers. (B) Normalized absorption, emission, and excitation spectra of [Eu(tta)3(22M)].179 Adapted from ref. 179 with permission from Wiley-VCH GmbH, Copyright©2022.

Piguet and collaborators have carried out an extensive work on lanthanide complexes derived from tridentate-nitrogen ligands. For example, they designed ligands 23–25 (Fig. 15) to further explore their coordination to a La(β-diketonate)3(diglyme) complex. They also conducted investigations to address the limited light absorption of Yb3+ and Er3+ ions, which limits their effectiveness in luminescent upconversion systems.180 For example, they generated ligand 26, which was functionalised with a cyanine antenna (Fig. 15), and the resulting Er(hfa)3(26) complex showed improved absorption of light, enhancing the efficiency of the upconversion. This approach addresses the typical low quantum yields seen in lanthanide-based molecular upconversion systems.181


image file: d5cs00750j-f15.tif
Fig. 15 Structural formulas of tridentate ligands 23–29.181,182,185,186

Lately, this ligand was further modified to give ligand 27 (Fig. 15). The coordination with Er(hfa)3 resulted in the formation of the [Er(hfa)3(27)]+ cationic complexes, which showed quantum yields and brightness that were two to three times higher than those of Er(hfa)3(26).182 Further theoretical183 and experimental studies in this topic were performed within the group to optimize the energy transfer mechanisms by introducing extended π-electron delocalization, flexibility and heavy atoms on the ligand skeleton.184

Additionally, they focused on the rational design of the nitrogen-tridentate ligands to improve the efficiency of lanthanide complexation. The authors found an enhanced affinity when using preorganized ligands by performing thermodynamic studies. The study revealed that the presence of rigid, planar and extended π-conjugated systems, as well as steric hindrance, is a crucial factor for binding trivalent lanthanide containers such as La(β-diketonate)3.187,188 Moreover, they reported that ligand 28 (Fig. 15), obtained by metal-templated synthesis using a Grubbs catalyst and neutral Ln(β-diketonate)3 where Ln = La3+, Eu3+, Gd3+, Y3+, and Er3+, is more efficient with the larger lanthanides. The metal complexes obtained Ln(β-diketonate)3 (28), which displayed better thermodynamic stability than those obtained with the precursor 29 due to the removal of the energy penalty associated with transtrans to ciscis reorganisation. The unique design of 28 opens a route to explore it as an Er-based upconversion system in soluble polymers.186

Although not as ubiquitous as dpa derivatives, the 2,6-bis(1,2,3-triazol-4-yl)pyridine (btp) moiety has also been used in developing monometallic Ln3+ complexes over the years.119,123 Monotopic btp derivatives exhibit strong chelating properties due to their rigid structure and were found to form highly stable tris complexes with a range of Ln3+ ions.119,189–191 The Gunnlaugsson group expanded upon previous research of the btp moiety by incorporating chiral ‘arms’ to yield compounds 30–32 (Fig. 16).192 The resulting Ln(L)3 (Ln3+ = Eu3+, and Tb3+) complexes gave rise to CPL spectra being mirror images of each other and confirming that the complexes were also enantiopure. A high quantum yield was obtained for the Tb(30)3 complex (Φ = 67%), whereas the analogous Eu(30)3 complex was significantly less emissive (Φ = 0.8%), suggesting that the antenna is a more efficient sensitiser for Tb3+.192


image file: d5cs00750j-f16.tif
Fig. 16 Structural formulas of chiral btp-derived ligands 30–32.192

Lately, Gunnlaugsson and colleagues developed three chiral tzpa ligands by combining btp and the dpa motifs, 33–35 (Fig. 17). They studied the complexation with Tb3+ ions giving rise to mononuclear complexes in all cases.193 It was found that ligands 33 and 34 form highly luminescent complexes Tb(L)3 under thermodynamic control exhibiting visible green emission, while under kinetic control, the Tb(L)2 complexes were obtained. These outcomes differed from previous studies with btp and dpa ligands, where the complexes showed the formation of an M(L)3 stoichiometry in both cases. Upon complexation with ligand 35, the formation of Tb(35)3 was found in acetonitrile. Moreover, it was observed that the q-value (number of water molecules directly coordinated to the lanthanide ions) was ca. 0, indicating full saturation of the Tb3+ coordination environment with ligand donor atoms. However, upon the addition of water, these complexes underwent dissociation. Nevertheless, these ligands offer a platform to explore tzpa-derived self-assemblies by performing structural changes on the btp and dpa cores to develop ligands with multiple binding sites to further obtain polymetallic supramolecular structures, something that the group has been actively working on in recent times (see discussion later on).


image file: d5cs00750j-f17.tif
Fig. 17 Structural formulas of ligands 33, 34 and 35.193

Recently, Patra and coworkers have reported the synthesis of two different bioprobes designed for the selective recognition of nucleoside phosphates (ATP, ADP or AMP), and for the detection of extremely toxic organophosphates (nerve agents such as DCP). These probes are based on Eu3+ complexes derived from ligands 36 and 37 (Fig. 18), and exhibit unique photophysical properties that can be modulated via their interactions with phosphate-derived molecules. Upon binding to these analytes, the complexes undergo changes in their emission intensities and lifetimes, giving rise to the modulation of luminescence responses.194


image file: d5cs00750j-f18.tif
Fig. 18 Structural formulas of ligands 36 and 37.194

2.4. Lanthanide self-assemblies derived from non-tridentate nitrogen-donor ligands

Although pyridine-centred tridentate motifs are widely used due to their ability to readily fulfil Ln3+ high-coordination requirements, other nitrogen donor ligand designs are also frequently employed within such designs.111,165,195–199 The Ung research group have done extensive research within the coordination chemistry of these types of ligands, for example, they designed the hexadentate ligand 38 (Fig. 19) and synthesised the derived lanthanide complexes of formula Ln(38)(OTf)3, Ln = Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, and Yb3+. They found that the Ln coordination environment differed depending on the Ln3+ ionic radius. All the complexes exhibited metal-centred emissions from visible (Sm3+, Eu3+, Tb3+, and Dy3+) to near-infrared (Nd3+ and Yb3+) regions, showing moderate to low quantum yields. Additionally, it was found that the Eu(38)(OTf)3 complex exhibits a C2 symmetry in solutions.200 They continued working to improve the sensitization for near-infrared emitting lanthanides by modifying the pyridine units of the ligand. The authors also reported enantiopure Sm3+, Eu3+, Tb3+, and Dy3+ lanthanide complexes derived from chiral ligands 39 and 40 Ln(L)(OTf)3 (Fig. 19), which were found to exhibit CPL with high dissymmetry factors.201,202
image file: d5cs00750j-f19.tif
Fig. 19 Structural formulas of ligands 38, 39 and 40.200–202

Recently, Piccinelli and co-workers have used β-diketone Htta together with ligand 41 (Fig. 20) to explore the effect of the counterion used in Ln3+ assemblies (Ln3+ = Sm3+ and Eu3+) on their resulting CPL signals.203 For the Eu(41)(tta)2 complex, the triflate counterion displayed a higher glum value than that of its nitrate counterparts. It was proposed that the observed CPL was the result of the difference in bond lengths between isomers. Moreover, they reported a series of water-soluble Eu(42)3 and Tb(42)3 complexes. Enantiopure ligand 42 (Fig. 20) was designed to provide a dissymmetric environment with the aim of exhibiting chiroptical features, whilst allowing further coordination from ancillary ligands. Notably, Tb(42)3 exhibited pronounced CPL activity, resulting in a glum value of 0.1 for the 5D47F5 transition, and is thus being studied as a potential CPL bioprobe in aqueous media.204


image file: d5cs00750j-f20.tif
Fig. 20 Structural formulas of chiral ligands 41 and 42.203,204

Li and colleagues used the bidentate ligands 43(R) or 43(S) (Fig. 21) and β-diketonate Hbtfa to form homochiral complexes with Sm3+ and Eu3+.205,206 The ligand design was based on previously reported work by Mamula et al.207,208 Both of the Ln(43)(btfa)3 complexes were emissive due to mechanical actions, known as triboluminescence (TL), as well as having CPL. Notably, the dissymmetry factors for the Sm3+ complex were found to be higher than those for Eu3+, which is a rare phenomenon, given that Sm3+ typically exhibits lower emission in CPL-active complexes.205 Moreover, they extended the work by synthesizing two chiral Pr3+- and Ho3+-derived complexes by combining ligands 43 with β-diketone Hdbm.


image file: d5cs00750j-f21.tif
Fig. 21 Structural formulas of bidentate ligands 43(R)/43(S) and β-diketones Hbtfa and Hdbm.205,206

These Pr3+ and Ho3+ complexes were found to exhibit NIR luminescence upon excitation at 410 nm. They also showed non-linear optical properties due to their non-centrosymmetric self-assemblies, displaying second-harmonic generation (SHG) and high third-harmonic generation (THG) responses; these are the first examples of NIR-emissive lanthanide-derived complexes showing such activities.206 Vomiero and co-workers used asymmetric bidentate ligand 44 with dibenzoylmethane (Hdbm) (Fig. 22) to obtain Eu3+ and Tb3+ complexes. The Eu3+ complex of formula Eu(44)(dbm)3 displays a quantum yield of 25% in the solid state. The complex was then incorporated into poly(methyl methacrylate) (PMMA) matrix for the preparation of luminescent plastic materials.209


image file: d5cs00750j-f22.tif
Fig. 22 Structural formula of asymmetric bidentate ligand 44.209

Moreover, de Bettencourt-Dias and coworkers expanded on their study (see Section 2.1) of the ability of generating cytotoxic single oxygen (1O2) of lanthanide complexes derived from oligothienyl-functionalized ligands 45–47 (Fig. 23). The lanthanide-derived complexes, [Ln(L)(COO)4] (Ln = Nd3+, Eu3+ and Yb3+), showed good IC50 phototoxicity values against HeLa tumour cells upon UV irradiation, the Nd3+ complex [Nd(46)(COO)4] being the most promising of these.210


image file: d5cs00750j-f23.tif
Fig. 23 Structural formulas of ligands 45–47.210

Within this class of ligands Charbonnière and colleagues have focused their recent effort on the development of supramolecular complexes with the ability of generating upconversion. They extended upon a previous study performed with ligand 48 (R = H) considering the promising photophysical properties that the Yb3+-derived complexes showed in water (Fig. 24),211 developing ligand 49 by using deuterium, with the aim of decreasing any nonradiative vibrational quenching due to the presence of C–H oscillators within the structure. The resulting complex, Yb(49), exhibited high luminescence and long lifetime (65 μs) in D2O, which is one of the longest reported to date. They also prepared polynuclear complexes in water, [(Yb48)2Tbx] or [(Yb49)2Tbx] (where x = 1–3), where the Tb3+-centred emission was observed for both complexes. These complexes were found to exhibit ytterbium to terbium upconversion sensitisation upon excitation at 980 nm.212 This work was further developed by the team when preparing [Ru(bpm)3(LnL3)3](BArF4)2 hetero-tetrametallic complexes, where Ln = Lu3+ and Yb3+. These complexes were obtained by using the [Ru(bpm)3]2+ core, where bpm is 2,2′-bipyrimidine, together with Ln(tta)(H2O)3 fragments. Particularly, the authors found that upon excitation at 980 nm, the Yb3+ complexes exhibited upconverted emission of the 3MLCT state of the central Ru(II) core at 636 nm. This represents the first example of an f → d molecular upconversion, offering new ways for the development of efficient upconverting molecular devices using heterometallic complexes.213


image file: d5cs00750j-f24.tif
Fig. 24 Structural formulas of ligands 48 and 49.211–213

More recently, Nonat and collaborators have reported two bispidine-based ligands containing chiral centres 50 and 51 (Fig. 25) and their Tb3+ complexes. The modifications in the ligand structure led to different complexation and luminescence properties, where the Tb(51) complex exhibited a higher luminescent quantum yield and stronger kinetic inertness, making it promising to future applications as a chiral luminescent probe.214


image file: d5cs00750j-f25.tif
Fig. 25 Structural formulas of ligands 50 and 51.214

An alternative approach to enhancing the functionality of supramolecular architectures involves the incorporation of multiple binding sites within the ligand design. By incorporating multiple sites for Ln3+ coordination within a ligand, the scope for the potential self-assemblies to be formed is increased. Therefore, the following sections will discuss in detail ligands with more than one binding site for Ln3+ ions and their resulting self-assemblies.

3. Recent advances in polymetallic Ln3+-derived self-assemblies

The formation of more complex intricate self-assemblies, as functional and responsive architectures, and higher order structures, remains one of the main objectives of supramolecular self-assembly chemistry. The use of lanthanides is particularly attractive in the design of such systems due to their unique coordination and physical properties, as discussed above. This section will focus on the development of such systems. Besides the increase in complexity of their resulting self-assemblies, the reported polynuclear Ln3+ systems developed to date have demonstrated to be promising in a range of applications such as in sensing,215–219 and hence, host–guest chemistry,220 imaging,221 single molecular magnets,222–224 and in the formation of other types of stimuli-responsive materials.28,29,57,96,225 The development of polymetallic Ln3+-directed self-assemblies over recent times is noteworthy and, as mentioned before, there are several in-depth reviews that provide some detailed insights into this fast emerging area of research within lanthanide chemistry.57,75,226–228

It is well known that the development of different lanthanide self-assembled architectures depends on multiple factors, making the prediction of the final architecture both complex and challenging.93 Moreover, the properties of the resulting complexes are highly dependent on their architecture. Thus, understanding the factors that control the formation of a specific supramolecular architecture, as well as the pathways through which these assemblies are formed is crucial to control their properties.

Normally, the formation of a supramolecular architecture can be concentration-dependent due to the labile non-covalent interactions between the ligands and the metal ions. In most cases, higher order supramolecular structures are obtained by increasing the overall concentration of both the metal ions and the ligands. Moreover, it was found that the stoichiometry of the complexes, as well as the architecture, could be metal ion-dependent. Furthermore, counter-anions and solvents are also factors that influence the local environment of the self-assembly, and hence, the final self-assembled architecture, as they can act as templates within the self-assembly process. Thus, a small modification in the reaction conditions (e.g. solvent polarity or metal salt used) can result in different supramolecular structures with diverse properties. Additionally, small changes in the ligand design and a variation in the metal ion used have shown a high effect on the final self-assembly architecture.227 In the next section, we will discuss in some detail the examples reported in recent years, highlighting the key advances and emerging trends within this field.

3.1. Lanthanide-derived helicates

The term ‘helicate’ was first introduced by Jean-Marie Lehn in 1987 to describe a class of self-assembled supramolecular copper compounds (linear polypyridyl ligands), exhibiting a helical-type architecture with similar characteristics to the double-helix structure of DNA.229 A supramolecular helicate consists of one or more organic ligands that are wrapped helically around a series of metal ions that define the axis of helicity. Since Piguet and co-workers reported the first dinuclear triple-stranded helicate with lanthanide metal ions in 1997,230 a vast array of lanthanide-derived helicate complexes has been described. Indeed, Bünzli and Piguet research groups, pioneered the field, and both researchers have carried out an extensive work on studying multimetallic Ln3+-directed (as well as using mixed d- and f-metal) assemblies throughout the years, providing key insights that have contributed significantly to the current state of the field.8

As mentioned above, recent studies have demonstrated that slight alterations to parameters such as the ligand[thin space (1/6-em)]:[thin space (1/6-em)]metal ratio (L[thin space (1/6-em)]:[thin space (1/6-em)]M), solvent, ligand design or concentration can significantly impact the architectures achieved in ditopic tridentate ligands, as well as their resulting photophysical properties.227,231,232 To achieve helicates, the ligand should fulfil specific requirements, such as, possessing flexibility, to enable to form stable helicoidal architectures upon metal ion coordination.13,233 Raymond and co-workers have showed that the use of C2-symmetric bis-bidentate ligands enables the achievement of M2L3 helicates. In addition, depending on the nature of the metal ion this could be more challenging, for example in the case of lanthanides, this is dictated by their large and variable coordination numbers. However, recent studies have demonstrated that small changes in the spacer length can be a key factor to achieve a specific architecture.58,234 Inspired by the architecture and structural characteristics of biological macromolecules, ditopic tridentate ligands are frequently used in designing polymetallic helicoidal Ln3+-derived self-assemblies. These systems possess two distinct binding sites for Ln3+ coordination, thus increasing the complexity of the self-assembly process, leading to the formation of 3[thin space (1/6-em)]:[thin space (1/6-em)]2 (L[thin space (1/6-em)]:[thin space (1/6-em)]M) supramolecular complexes, such as helicates. Among the wide variety of tridentate ligands, the dpa motif is one of the most extensively used, due to its versatility in developing both monometallic and polymetallic Ln3+-derived assemblies.

Over the years, the Gunnlaugsson group has synthesised many examples of ditopic dpa ligands featuring chiral naphthalene arms for the development of Ln3+-derived helicates.235–237 These chiral arms act as an antennae alongside the dpa binding units and play a key role in sensitising and enabling the CPL of the Ln3+ ions. More recently, Kotova et al. have investigated how differences in spacer sizes in ditopic dpa-based symmetric ligands affect the overall photophysical properties of the resulting Eu2(L)3 (L = 52–54) (Fig. 26) complexes through in situ studies.231


image file: d5cs00750j-f26.tif
Fig. 26 Structural formulas of chiral dpa-derived ligands 52–58.231,239,240

For these examples, ligands 52 and 53 feature a short aryl spacer, while the ligand 54 displays a bulkier spacer possessing a cyclohexane ring. The examination of the spectroscopic titration data (i.e. carried out under kinetic control), where the UV-Vis, the fluorescence of the ligand and the delayed lanthanide emission were monitored and fitted using non-linear regression analysis software, showed that 52–54 all formed species Eu(L)2, Eu2(L)2 and Eu2(L)3, with Eu2(L)3 being the dominant species (normally formed in ca. 90–95% yield) upon the addition of 0.67 equivalents of the metal ions, with slightly higher binding constants when the linker between the dpa moieties was shorter (52 and 53), and the other species being formed at higher Ln-ion equivalents.

Furthermore, further photophysical studies of the Eu2(L)3 complexes revealed negligible differences in their luminescence lifetimes. However, the quantum yield decreased with ‘increasing’ the hindrance of the linker, which was also accompanied by a decrease in the corresponding ηsens (the sensitisation efficiency) value of the Eu3+ centers within the self-assembly structures.

The Gunnlaugsson group has further expanded on their ditopic dpa ligand designs, reporting compounds 55(R,R) and 55(S,S) (Fig. 26) and their self-assembly with Eu3+ in protic polar solvents.238,239 The resulting helicates Eu2(55(R,R))3 and Eu2(55(S,S))3 were obtained in high yields (78% and 71%, respectively, under thermodynamic control), with Eu(III)-quantum yields of 3.5% and 3.2% in methanol and 4.1% and 4.4% in acetonitrile, respectively.238 These values were again lower than their previously reported mononuclear trinuclear ‘sliotar’ counterparts, which could be attributed to the lower efficiency of sensitisation between the ligand antenna and the Eu3+ core, and increased quenching pathways within Ln2L3 structures compared to LnL3 ones.137 The studies of higher order assemblies using Eu2(55(R,R))3 showed that their thin LB films were formed only when using acetonitrile, while exclusive formation of monodisperse spherical aggregates was observed from methanol or methanol/water mixtures.

Recently, researchers in the Gunnlaugsson group have also reported the in situ formation of dimetallic triple stranded helicates using the tzpa ligands 56(R,R) and 56(S,S) (Fig. 26).239 As triazol ligands show higher sensitisation of Tb3+-centred emissions, these were formed (under thermodynamic control) as Tb2(56)3, and the subsequent self-assembly studies (under kinetic control) between 56 and Tb3+ in solution suggested the formation of 2[thin space (1/6-em)]:[thin space (1/6-em)]2 and 2[thin space (1/6-em)]:[thin space (1/6-em)]3 M[thin space (1/6-em)]:[thin space (1/6-em)]L dimetallic helicates, where Tb2(56)2 stoichiometry was the dominant.

More recently, the group has expanded its research by modifying the tzpa motif and synthesizing the first examples of tzpa ligands with carboxylic methyl ester (57) and long hydrophobic alkyl chains (58). It was anticipated that the incorporation of hydrophobic chains into the ligand would facilitate the formation of higher order self-assembly architectures.

They also performed the synthesis of the derived luminescent di-metallic triple-stranded Tb3+ helicates [Tb2(L)3], under both thermodynamic and kinetic control. The material features of the helicates were investigated using SEM imaging in a range of solvents, where it was established that they exhibited different morphological features, not only when compared to the ligands, but also between both types of helicates (e.g. short vs long alkyl chains).

Recent examples of the dpa motif employed in ditopic ligands included the incorporation of the moiety into ligand 59 (Fig. 27(A)), as reported by Yan and co-workers, which also featured a photochromic diarylethene spacer.241 The presence of the photochromic diarylethene spacer plays a key role in this design, as it enables light-driven control over metal coordination, this being of particular interest for developing light-driven molecular switches. Self-assembly with Eu3+ resulted in the formation of the chiral Eu2(59)3 helicate, which displayed conformational changes when exposed to UV irradiation at 275 nm. This process was reversible, as when Eu2(59)3 was exposed to visible light irradiation at 526 nm, the switching was returned to its original form (Fig. 27(A)) with concomitant changes in the spectroscopic readout. Interestingly, in the closed-ring state, the complex exhibited a decrease in the Eu3+ luminescence, as well as a decrease in the CPL glum values, thus establishing Eu2(59)3 as a reversible optical and chiroptical switch.


image file: d5cs00750j-f27.tif
Fig. 27 (A) Structural formula of ligand 59 and structural reversible change of the Eu2(59)3(OTf)6 helicate upon alternating UV and visible light irradiation.241 (B) Ligand 60 and optimized structure of the M-(ΛΛ)-Eu2(60(R,R))3 helicate. Photoirradiation at 334 nm transforms the open form of the diarylethene moiety into a closed form and can be reversed back upon irradiation at 630 nm.242 Adapted from ref. 242 with permission from the Royal Society of Chemistry, Copyright©2018.

Sun and co-workers reported compound Eu2(60(R,R))3, which is the first example of a chiral photoresponsive helicate derived from a dithienylethene ligand 60.242 As for the previous example, both 60 and its resulting Eu3+ helicate exhibited a UV-induced conformation. Furthermore, the study revealed a transfer of chirality from 60 to the Eu3+ centre, resulting in the formation of P or M diastereomers, respectively (Fig. 27(B)).

The authors also developed the hexameric lanthanide-organic capsule derived from tzpa ligands 61 and 62(R,R)/(S,S) (Fig. 28).220 Upon complexation of ligand 61 with Eu(OTf)3, a Eu2(61)3 triple-stranded helicate was isolated. However, when the ligand underwent complexation with Eu(ClO4)3, a concentration-dependent formation of a new species occurred, which became the dominant species at concentrations above 72.6 mM, mimicking the self-assembly process of the R6 insulin hexamer. Through ESI-TOF-MS, the new concentration-triggered species, [Eu2(61)3]6(ClO4)36, were elucidated. The hexamerisation of Eu2(61)3(OTf)6 was also achieved by adding ClO4 to a solution of this species, as confirmed using 1H NMR titration studies. A solvent-triggered helicate-to-hexamer transformation was observed by adding THF-d8 to a solution of [Eu2(61)3]6(ClO4)6 in a CD3CN:CD3OD (c = 0.02 mM) mixture, leading to the appearance of [Eu2(61)3]6(ClO4)36. During this process, aggregation-induced emission (AIE) behaviour was also observed, with a decrease in the Eu(III)-centred emission initially, followed by a 2.5 times enhancement as the THF content increased, together with an increase in the Eu3+ quantum yield from 22.8% to 46.2%. Furthermore, excited-state lifetime measurements showed the presence of a longer decay in CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]THF (1[thin space (1/6-em)]:[thin space (1/6-em)]29) compared to that measured in CH3CN alone.220 This outcome confirms a complete helicate-to-hexamer transformation triggered by solvent conditions. The hexameric [Eu2(61)3]6(ClO4)36 assembly also displayed aggregation-induced water stability, which is a highly favourable property owing to many polynuclear Ln3+ assemblies dissociating under aqueous conditions. Further host–guest studies on this system have demonstrated that the [Eu2(61)3]6(ClO4)36 system exhibits encapsulation and selectivity towards terpene drugs within the central cavity of the hexamer. The chiral analogue ligands, 62(R,R)/(S,S), formed enantiopure Eu2(62)3 complexes, which subsequently resulted in the formation of enantiopure [Eu2(62)3]6(ClO4)36 hexamers. This was confirmed through CD and CPL studies.220


image file: d5cs00750j-f28.tif
Fig. 28 (A) Structural formulas of the ligands 61, 62(R,R) and 62(S,S). (B) Cavity volume and enantiopure chiral cavities of [Eu2(61)3]6(ClO4)36.220 Adapted from ref. 220 with permission from the American Chemical Society, Copyright©2021.

A similar type of linker was used by Sun and co-workers who reported the self-assembly of 63(R,R)/(S,S) with La3+, where a 2/3 M/L ratio resulted in a bimetallic triple-stranded helicate La2(63)3. By changing the M/L ratio to 1/1, the resulting self-assembly changed to a mononuclear pincer complex, La(63) (Fig. 29). CD studies revealed that both supramolecular structures were found to be enantiomeric. Subsequently, the catalytic properties of both complexes were investigated in relation to asymmetric Friedel–Crafts alkylation reactions. In these reactions, La2(63)3 showed a lower yield but higher enantiomeric excess products compared to La(63).243


image file: d5cs00750j-f29.tif
Fig. 29 Coordination-directed stereo-controlled self-assemblies derived from ligands 63(R,R)/(S,S) and 64(R,R)/(S,S) by varying the metal/ligand ratio.243,244 Adapted from ref. 243 and 244 with permission from the Royal Society of Chemistry, Copyright©2021 and 2022.

The authors completed this work by changing the chiral naphthalene groups for an achiral isopropyl amine, giving rise to the ligand 64 (Fig. 29). This modification of the ligand design resulted in the formation of mono-ligand bridged dinuclear La3+ complex La2(64)3 when the M/L ratio is 2/3, while when the ratio was 1/1, a La3+-derived polymer, [La2(64)2]n, was obtained.

It has been shown that by adding ligands or lanthanide ions between these structures, the reversible formation of both structures could be achieved. Moreover, the authors added the chiral ligand 20 to the self-assembly to induce chirality into the complexes, leading to the mononuclear La(64)(20) self-assembly, which exhibits a CD signal and can be used to determine the enantiomeric excess. This strategy demonstrates the versatility of lanthanide-derived self-assemblies and provides a new method for enantiomeric excess sensing.244

Sun and co-workers extended their research by synthesising enantiopure bis-tridentate ligands, featuring both an axial and a point chirality, having reported the stereo-controlled self-assembly process of a family of both homochiral and mesomeric La3+ and Eu3+ triple-stranded helicates. Using CD and CPL spectroscopy, it was revealed that axial chirality was a key factor in determining the configuration of the metal ion centre, controlling the helicity of the supramolecular architecture. The resulting homochiral helicates demonstrated enhanced enantioselectivity in the luminescent detection of D/L-leucinol, highlighting the importance of precise stereochemical control for optimizing the applications of the functional materials.245

As mentioned above, Piguet and colleagues have also carried out extensive research within the field of helicates derived from lanthanides.246,247 For example, they reported a study revealing the possibility of the thermodynamic self-assembly formation of luminescent heterodimetallic helicates, by using the hexadentate gallium-based tripodal ligands 65 and 66 (Fig. 30).248 Kinetic analysis showed that the [GaLn(L)3]6+ helicates (where Ln = Y3+, Eu3+, and Er3+) retain the triple-stranded helical structure even when exposed to lanthanide exchange conditions. They also reported that the attachment of a second ligand slows down the metal exchange process, allowing the closed–shell [GaYGa(66)3]9+ to be used as an inactive matrix for diluting the open–shell [CrErCr(66)3]9+ structural isomer. This leads to the detection of molecular upconversion at room temperature, opening up the way for optimizing processable, NIR to visible upconverting materials.233 They further extended their investigations to heterometallic helicates derived from d- and f-metal ions, although these are not discussed in this review.249–251


image file: d5cs00750j-f30.tif
Fig. 30 Structural formulas of ligands 65 and 66 synthesised by Piguet and colleagues.248

Riddell and co-workers investigated the effect of the ligand backbone symmetry on polynuclear lanthanide self-assemblies. By changing a symmetric ethylene linker with an asymmetric amide (Fig. 31), they discovered the formation of a Ln6(67)6 complex (Ln = Sm3+, Eu3+, Gd3+, and Tb3+), with unsaturated metal centres. Moreover, the counter-ions and the ionic radii of Ln ions were found to be a key factor in the final architecture of the complex.252 It was found that when the central amide moiety in ligand 67 was changed for an ethylene bridge, ligand 68, a Ln2(68)3 complex, was obtained, indicating the formation of a helicate. These complexes showed different luminescence properties, with Eu6(67)6 exhibiting shorter luminescence lifetimes and lower quantum yields, than Eu2(68)3. This demonstrates the role of the ligand design on the self-assembly process and on the luminescence properties of the complexes.252


image file: d5cs00750j-f31.tif
Fig. 31 Structural formulas of ligands 67 and 68 synthesised by Riddell and co-workers.252

3.2. Lanthanide-derived metallocages

Besides the study of helicate systems, there has been a recent focus on the employment of the ditopic tridentate motif to achieve other higher-order assemblies. Lanthanide metallo-cages are interesting self-assembled architectures with potential applications in different fields such as catalysis, sensing, host–guest, imaging or magnetism.253–255 Metallocages are three-dimensional architectures formed by the coordination of multidentate ligands to metal ions positioned at the vertices of the cage. It is well known that the design of the ligand influences the final architecture of the metallo-supramolecular structure, and thus, on its functionality. Different characteristics such as the size, or the flexibility of the ligands employed, are known to be key factors for the self-assembly of metallocages. Thus, a flexible ligand usually leads to metal complexes with low nuclearity, while rigid ligands used to favour polynuclear compounds. Hence, the size and shape of the final architecture of the complex can be controlled by the distance and the orientation of the donor atoms.256 Moreover, the presence of bulky groups, as well as the length-to-width ratio of a ligand, or the metal ion size, can be used to control the self-assembly process.253,257,258

The Sun group has been particularly active in developing this topic, with their effort leading to significant research in recent years on Ln3+-directed polymetallic assemblies, including the design of low-symmetry lanthanide metallocages that can distinguish and bind selectively to higher fullerene isomers.259

As an example of the metallocages prepared by Sun and co-workers, then they reported ligands 69–72 for the purpose of exploring how increasing the distance of the linker between dpa moieties affects the self-assembly process with Ln3+ ions (Fig. 32).260


image file: d5cs00750j-f32.tif
Fig. 32 Structural formulas of ligands 69–72 synthesised by Sun's research group.260

The Sun group found that when the spacers are flexible (e.g. ligands 69 and 70), a mixture of helicates Ln2(L)3 and metallo-cages Ln4(L)6 are formed. However, by using rigid spacers (e.g. ligands 71 and 72), a mixture of a helicate Ln2(L)3 and a cubic complex with the formula Ln8(L)12 are formed, as shown in Fig. 33, the formation of which depends on the concentration. These cubic-derived complexes were found to have potential as ‘switch-off’ sensors towards explosives, with high selectivity and sensitivity for the electron-deficient nitroaromatic compound picric acid.260 This study further confirmed how small changes in the ligand structure can have influence on the outcome of the supramolecular architecture of the complexes, and thus on their properties.


image file: d5cs00750j-f33.tif
Fig. 33 X-Ray crystal structure of the mixture of Eu2(70(R,R))3 and Eu4(70(R,R))6, with only one helicate (left) and one tetrahedron shown for clarity (highlighted blue and green, respectively), and Nd8(72)12, where Nd = purple; C = white; N = dark blue; O = red; H = cyan (right).260 Adapted from ref. 260 with permission from the American Chemical Society, Copyright©2017.

The authors also designed ligands 73 and 74 (Fig. 34), where the tridentate moiety combines the carboxamide unit of dpa and the oxazoline of pybox.232


image file: d5cs00750j-f34.tif
Fig. 34 (A) Structural formulas of ligands 73 and 74. (B) Fluorescence emission spectra of Eu4(73)6(OTf)12 (c = 1 × 10−5 M) in CH3CN upon addition of picric acid (λex = 350 nm), Inset: Stern-Volmer plot, reported by Sun and colleagues.232 Adapted from ref. 232 with permission from the Royal Society of Chemistry, Copyright©2017.

Upon self-assembly with Eu3+, it was observed that both ligands formed Eu2(L)3 helicates (L = 73, 74). However, when 73 underwent self-assembly with Eu3+ at a high concentration (4.8 × 10−1 M), the tetrahedral cage Eu4(73)6 was shown to be formed. This represents the first reported example of a transformation induced by concentration. This complex exhibited high stability and did not reassemble into the Eu2(73)3 species upon dilution. Furthermore, the ability to detect electron-deficient nitroaromatics was demonstrated, with a notable selectivity towards picric acid at the pbb level. In contrast, the Eu4(74)6 species were not observed under the same high-concentration conditions and only the Eu2(74)3 helicates were present. This outcome is attributable to the less sterically constrained nature of the linker, which favours the formation of a helicate.232

Later, the authors reported an attractive new approach towards polynuclear water-stable Ln3+-directed self-assemblies with potential applications for bioimaging and drug delivery.261 The rationale behind the ligand design, which involved the joining of both tridentate motifs through the 4-pyridyl position (Fig. 35), was to develop a more rigid ligand that would in turn aid in the formation of more stable polynuclear structures with Ln3+.


image file: d5cs00750j-f35.tif
Fig. 35 Structural formulas of ligands 75–77 reported by Sun and colleagues.261

When ligand 75 reacted with Ln(OTf)3 (Ln3+ = Eu3+, Gd3+, and Tb3+) in a 3/2 L/M ratio alongside 12 equivalents Et4NOH in DMSO ([(Et4N)4(75)] = 1.44 × 10−5 M in DMSO), a mixture of self-assemblies with the stoichiometry Ln4(75)6 and Ln6(75)9 were obtained. Moreover, an increase in ligand concentration resulted in the formation of more complex structures such as Ln6(75)9. It was also observed that the existence of the Ln4(75)6 complex was not a result of the dissolution of the Ln6(75)9 complex. When 76 or 77 underwent identical complexation conditions, the predominant self-assembly was Ln8(L)12.261 When the base was switched from Et4NOH to KOH, then this resulted in the formation of crystals with the chemical formula K18Eu6(75)9, which were obtained by slow diffusion of acetone into DMSO. Upon dilution of the solution to the concentration of 10−4 M, a total transformation of K18Eu6(75)9 to K12Eu4(75)6 was achieved.

In the case of 76, the use of KOH as the base resulted in the observation of a mixture of both K24Eu8(76)12 and K30Eu10(76)15. Furthermore, treatment of 77 with EuCl3 and KOH in water at lower concentrations (∼10−6 M) resulted in the formation of K30Eu10(77)15 self-assembly. The attempts to crystallize K30Eu10(77)15 resulted in a gradual transformation of this assembly to the octanuclear K24Eu8(77)12 complex, suggesting that its formation was the thermodynamic product (Fig. 36). This investigation illustrates the intricate effects that the choice of Ln3+ salt, solvent, base and concentration conditions have on the resulting self-assemblies formed.261 Furthermore, it was later shown that the stability and luminescence performance of such systems can be increased through embedding them into mesoporous silica using a “ship-in-a-bottle” synthetic strategy.284


image file: d5cs00750j-f36.tif
Fig. 36 Crystal structures of (A) K24Eu8(76)12, (B) K18Eu6(75)9, and energy optimised structures of (C) K30Eu10(77)15, and (D) K12Eu4(75)6.261 Adapted from ref. 261 with permission from the American Chemical Society, Copyright©2020.

Photophysical studies on these systems demonstrated the attractive luminescence properties of Tb8(76)12 and Eu8(77)12 complexes, exhibiting high quantum yields in DMSO and water. Moreover, the Gd8(77)12 complex exhibited a considerably prolonged retention time in tumour sites in comparison to commercially available Gd3+-containing contrast agents, suggesting its potential application as a magnetic resonance imaging contrast agent. The mixed Gd3+/Eu3+ cages have potential as dual-mode imaging agents, making these complexes unique in nature.261

Sun's group has continued its effort within this area of research and reported a series of Ln3+–Pt3+ (Ln3+ = Nd3+, Eu3+, Yb3+, and Lu3+) cages based on dpa-containing ligands 78 and 79 (Fig. 37).262 The Pt3+–acetylide unit was specifically chosen for its use in photo-functional complexes as well as its ability to efficiently sensitise Ln3+ via metal-to-ligand charge transfer (MLCT). This property allowed the excitation to the visible region in the case of Nd3+- and Yb3+-based cages. Furthermore, it was observed that the Ln4(79)6 (Ln3+ = Eu3+ and Yb3+) assembly showed temperature-dependent red and near-infrared emission properties. Therefore, the resulting Ln4(79)6 complexes were tested as potential temperature sensors. The different angles of the ligands resulted in either helicates or tetrahedral cages upon self-assembly with Ln3+.


image file: d5cs00750j-f37.tif
Fig. 37 Stereo-controlled self-assembly of heterometallic cages derived from 78 and 79.262 Adapted from ref. 262 with permission from the American Chemical Society, Copyright©2022.

In a related study, the Sun group designed C2-symmetric triazole-derived ligands with different linear lengths in the spacer with the aim of obtaining multinuclear luminescent Eu3+-derived metallo-cages. They found that by increasing the length of the spacer, the self-assembly process was indeed modulated. In the case of the shorter spacer (with one phenyl ring), a tetranuclear Eu4L6 metallo-cage was obtained, while with the larger spacer (three phenyl rings) the ‘classical’ dinuclear Eu2L3 helicate was formed. In the case of the ligand with two phenyl rings in the spacer, a mixture of a helicate and a metallo-cage was obtained. However, when the concentration of this ligand was increased, the complete transformation of the helicate to the cage compound occurs, in a similar manner to that described above. The resulting Eu-based cages exhibited high luminescence and also gave rise to CPL. This study is another approach for the development of lanthanide-based cages.263

Lately, the authors have designed stereoselective self-assembly ligands 80(R,R)/80(S,S) (Fig. 38), to achieve enantiopure tetrahedral complexes derived from Sm3+, Eu3+ and Yb3+.264 The authors achieved the formation of enantiopure tetranuclear metallo-cages, Ln4(80)6, with the metal stereochemistry defined by using the C2-symmetric ligands 80(R,R)/80(S,S). In the cases of YbEu4(80)6 and YbSm4(80)6, these tetrahedral complexes exhibited the ability of emitting upconverted circularly polarized luminescence (UCCPL), being the first example of UCCPL in lanthanide supramolecular complexes.


image file: d5cs00750j-f38.tif
Fig. 38 Self-assembly of metallo-cages derived from 80(R,R)/80(S,S).264 Adapted from ref. 264 with permission from the Chinese Chemical Society, Copyright©2025.

In addition to concentration-triggered helicate to other higher-order structural transformations, Law and co-workers have reported ditopic dpa-based ligands 81–83 (Fig. 39), where the use of rigid 2,6-diaminoanthraquinone as a linker was shown to favour the formation of tetrahedral cages when undergoing Ln3+-directed self-assembly.265 The arms of these ligands, although similar, contained different point chiralities with the aim to investigate how these small differences affect the self-assembly process with Eu3+.


image file: d5cs00750j-f39.tif
Fig. 39 Structural formulas of ditopic dpa-based ligands 81–83.265

The differences observed in the CPL and the CD, as shown in Fig. 40, and in the 1H NMR spectra of the resulting Eu3+ tetrahedral complexes can be attributed to the varying degrees of stereoisomerism within each system, where the complexation of 81(R,R) or 81(S,S) with Eu(OTf)3 leads to a highly stereoselective formation of either ΛΛΛΛ-[Eu4(81(R,R))6](OTf)12 or ΔΔΔΔ-[Eu4(81(S,S))6](OTf)12.


image file: d5cs00750j-f40.tif
Fig. 40 (A) Circular dichroism spectra of Eu4(L)6 (L = 81–83). (B) Circularly polarised luminescence spectra of Eu4(L)6. (C) Scheme depicting the reasoning behind the differences observed in chiroptical intensity.265 Adapted from ref. 265 with permission from Springer Nature, Copyright©2017.

Conversely, the use of either enantiomer of 82 or 83 under the same reaction conditions resulted in a formation of a mixture of both isomers. Intriguingly, compound 83 exhibited slightly better selective stereocontrol in comparison to 82, despite the location of its point chirality being further away from the coordination site. This finding suggests that steric effects may have a more significant influence on the diastereoselectivity of the resulting Eu3+ cages than that of point chirality.265

More recently, the authors have demonstrated that the linker length and ionic radii of the Ln3+ ion employed in the formation of such self-assemblies may influence the helicate-tetrahedral transformation of ditopic dpa-based ligands L,266 such as in the case of 84 and 85 (Fig. 41).234


image file: d5cs00750j-f41.tif
Fig. 41 Structural formulas of ditopic dpa-based ligands 84 and 85.234

A tetrahedral single-crystal structure Eu4(84(S,S))6 was obtained by diisopropyl ether diffusion into the solution of Eu2(84(S,S))3 helicate in a CH3CN solution. Remarkably, only the helical species were observed when using the analogous ligand containing the linker with two aromatic rings266 and ligand 85 containing three aromatic rings (Fig. 42).


image file: d5cs00750j-f42.tif
Fig. 42 Single-crystal X-ray structures showing the formation of helical or tetrahedral (Eu4(84(S,S))6) structures, respectively.234 Adapted from ref. 234 with permission from Springer Nature, Copyright©2021.

This behaviour can be attributed to the linkers of both ligands being longer with more rotational freedom, suggesting that the length and flexibility of the chosen linker affect the self-assembly process. Thus, it was observed that by increasing the length of the spacer, the helicoidal structure was favoured, as was seen with 85, while the shorter linker in 84 gave rise to a tetrahedral architecture. Moreover, the larger Ln3+ ions tend to form dimetallic helicates while smaller ones form tetrahedral cages, where Lu4(L)6 was shown to be the most stable one.234

The authors further expanded these studies and reported the formation of heterometallic LnnLn4–n(70)6 (n = 0–4) tetrahedral complexes.267 The mixture of Eu2(70)3 and Ln2(70)3 (Ln3+ = Gd3+, Tb3+, and Dy3+) helicates in a 1/1 ratio resulted in single crystals suitable for X-ray analysis via slow ether diffusion into CH3CN. It was found that upon crystallization of a mixture of Eu2(84)3 and Gd2(84)3 in a ratio of 1/1, a heterometallic cage was obtained with the formula EunGd4−n(84)6 (n = 0–4). Differentiation between Eu3+ and Gd3+ by X-ray crystallography was not possible due to their similar electron densities. However, the use of mass spectrometry convolution studies enabled the differentiation of the ratio of Gd3+ to Eu3+ in the tetrahedral complexes, where Eu2Gd2(84)6 was identified as the predominant species, being formed in 46% yield, and the unique heterometallic species were detected. A similar result was obtained for a mixture containing both Eu2(84)3 and Tb2(84)3 complexes.267

3.3. Multimetallic lanthanide cages from tripodal ligands

Another approach allowing for the formation of multimetallic Ln3+ assemblies, such as cages, involves the use of tripodal ligands. Their rigid design, with three distinct binding sites for Ln3+ ions, allows for greater control over the ‘pre-organization’ of ditopic tridentate ligands, as the competing self-assembly of helicate systems is absent. The Sun research group have carried out work on this topic, describing the formation of tetrahedral cages from the self-assembly of the tripodal ligands 86 or 87 (Fig. 43), bearing the pybox coordination moiety, with Eu3+ ions.268 Interestingly, it was observed that the quantum yield (in acetonitrile) of Eu4(86)4 was considerably higher than that of Eu4(87)4 being 10.2% vs. 0.24%, respectively. This phenomenon can be attributed to the intraligand charge transfer (ILCT) sensitization of the Eu3+ core, which contrasts with the conventional T1 sensitization process typically employed in Ln3+ self-assemblies. Furthermore, the Eu4(86)4 complex was found to have promising sensing properties towards inorganic ions, exhibiting a ‘turn-off’ of the Eu3+-centred luminescence upon addition of I ions and an enhancement in Eu3+-centred luminescence in the presence of Cu+ cations.268
image file: d5cs00750j-f43.tif
Fig. 43 Structural formulas of tripodal ligands 86 or 87.268

The authors have also incorporated the tzpa moiety into tripodal systems, 88 and 89 (Fig. 44), with the aim of forming cages.269 The self-assembly of either of these ligands with Ln(OTf)3 (Ln3+ = Sm3+, Eu3+, Tb3+, Dy3+, and Er3+) yielded Ln4(L)4 cages. High quantum yields were obtained for Tb4(89)4 (50.8%), as well as for Eu4(88)4 (51%) and Eu4(89)4 (56.6%) in an acetonitrile solution. As compound 89 was shown to efficiently sensitise both Eu3+ and Tb3+, mixed hetero-metallic cages were formed by reacting 89 with Eu3+ and Tb3+ in a 1/1 ratio, resulting in the formation of the self-assembly EuxTb4−x(89)4(OTf)12 (x = 0–4). The potential of these mixed lanthanide cages to act as radiometric luminescent thermometers was investigated by examining the luminescence of the EuxTb4−x(89)4(OTf)12 (x = 0–4) cages in the temperature range from 80 to 400 K. An increase in temperature (from 200 to 360 K) resulted in a significant decrease in the Tb3+-centred emission at 545 nm (5D47F5), accompanied by an enhancement in the Eu3+-centred luminescence at 616 nm (5D07F2) owing to an energy transfer process from Tb3+ to Eu3+. This temperature-dependent luminescence change could also be observed by the naked eye, as a colour change from green to red was observed in the solution.269


image file: d5cs00750j-f44.tif
Fig. 44 Structural formulas of tripodal ligands 88–93.269–271

More recently, the authors have expanded on this work by using analogous tripodal systems based on ligands 90 and 91, where the angle between the spacer and the chelating tzpa moiety is 120°, in contrast to the 180° observed for tripodal ligands 88, 89, 92 and 93 (Fig. 44).270 This small change in ligand design resulted in the first example of the formation of Eu3L3 ‘sandwich’ structures upon self-assembly with Eu3+, in contrast to the more prevalent Eu4L4 tetrahedral cage structures. The findings of the self-assembly studies indicated that while 91 solely formed the Eu3(91)3 complex, the solvent-triggered transformation between Eu3(90)3 or Eu4(90)4 complexes was also observed.

Sun and co-workers have also introduced the tzpa moiety with an external triazole unit into ligand 92 and the btp motif with compound 93 (Fig. 44). It was found that 93 was able to efficiently sensitise the luminescence of all emitting Ln3+ ions spanning both the visible and NIR regions (Ln3+ = Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Er3+, Tm3+, and Yb3+), with a record high quantum yield obtained for Tb4(93)4 (Φ = 82%) in the acetonitrile solution. The high quantum yield exhibited by these lanthanide organic polyhedra (LOPs), particularly those employing 89 and 93, prompted an investigation into their potential as white light emitters (WLEs). It was established that the International Commission on Illumination (CIE) chromaticity coordinates for [Eu4(89)4]2[Tb4(89)4][89]35 (0.33, 0.33) in a DCM/MeOH (1/1 v/v) solution excited at 374 nm, or [Eu4(93)4]2[Tb4(93)4][93]230 (0.33, 0.34) and [Sm4(93)4][Dy4(93)4]7.5[93]80 (0.34, 0.34) by exciting at 330 nm were found to be optimal for WLE systems.271

The authors have also designed chiral ligands to achieve Ln4L4 tetrahedral cages with the aim of understanding the ionic radius-dependent kinetics and the chiral amplification during the self-assembly processes. The obtained results indicated that the complexes are formed slower when using lanthanide ions with a smaller ionic radius. They found that in the case of Ln4L4 cages with mixed chiral and achiral ligands, then upon using the lanthanide ions La3+ and Pr3+, respectively, the self-assembly of the cages and their chiral amplification occur simultaneously. However, in the case of Eu4L4, two different steps were found to occur in the cage formation: first of these being assigned to the self-assembly followed by chiral amplification. This different kinetic behaviour could, however, also be due to the different ligand exchange rates.272

Lately, Sun and colleagues reported the first example of a radical-bridge lanthanide tetrahedral cages obtained by self-assembly between a radical ligand derived from triphenylamine and Ln3+ ions (Ln = La3+, Eu3+, Gd3+, Tb3+, and Lu3+). The stability of the cages derived from paramagnetic ions (Eu3+, Gd3+, and Tb3+) was higher, and this could be due to the magnetic interactions between these ions and the radical ligands. This study presents an approach for the development of stable radical-based systems with potential applications as lanthanide-derived smart materials.273 Additionally, they prepared luminescent films based on Eu4L4 tetrahedral cages derived from two triarylborane-cored tritopic ligands. Both films exhibited strong luminescence properties, and high sensitivity towards volatile amines with a high level of detection (sub-ppt level). Within these results, they demonstrate the potential of lanthanide cage-based films in sensing applications.274

In a recent study, Kotova et al.275 have developed a tripodal ligand based on the dpa design (Fig. 45), employing a similar strategy to that shown in ligand 7.151 This was achieved by developing compound 94, which possesses a 1,3,5-benzenetricarboxiamide core, joining to three dpa moieties through the 4-pyridyl position of the dpa center.275 Titration studies of 94 with Eu(OTf)3 revealed the expected formation of 1[thin space (1/6-em)]:[thin space (1/6-em)]1, 2[thin space (1/6-em)]:[thin space (1/6-em)]1 and 3[thin space (1/6-em)]:[thin space (1/6-em)]1 (M:L) species in situ, where the lanthanide emission was highly modulated depending on the nature of the speciation in the solution. This design offers the potential for the development of higher order structures through further synthetic modification of the dpa unit at the esters.


image file: d5cs00750j-f45.tif
Fig. 45 Structural formula of tripodal ligand 94 based on the dpa design.275

Despite the prevalence of the tridentate ligand motif in the formation of complex higher order self-assemblies, there have been several examples developed using non-tridentate ligand designs. Like their mononuclear counterparts, non-terdentate binding motifs are also used in the formation of polymetallic Ln(III)-directed self-assemblies. For example, Sun and co-workers have reported the formation of the tetradentate tripodal acylhydrazone ligand 95 with the ability to form self-assembled octahedral metallocages derived from Lu3+, Yb3+ and Eu3+, as shown in Fig. 46.276 These metallocages exhibited charge-reversibility depending on the pH of the media. This enables controlling the structure of the cage and the encapsulation/release of different ionic guest molecules by changing the pH of the media, resulting in a potential candidate for the development of smart luminescent supramolecular materials.


image file: d5cs00750j-f46.tif
Fig. 46 (A) Structural formula of ligand 95. (B) X-ray single-crystal structure of Δ3Λ3-(Et4N)6Eu6(95)4.276 Adapted from ref. 276 with permission from the American Chemical Society, Copyright©2023.

More recently, Zang and co-workers have reported two different lanthanide self-assembled octahedral metallo-cages by using Eu3+ and Tb3+ ions together with the tri(β-diketone) ligand 96 (Fig. 47).277


image file: d5cs00750j-f47.tif
Fig. 47 Structural formulas of ligand 96 and arginine.277

In this study, they successfully demonstrated the ability of inducing CPL by using specific amino acids that can modify the chiral environment around the Ln3+ ions; the chiral induction of the racemic mixture was achieved with arginine, showing the highest CPL metrics for Eu3+ to date (glum = 0.53, FM value = 0.323). The authors further studied the mechanism underlying this induced CPL phenomenon and suggested that the induction efficiency increases while increasing the coordination number of the amino acids or the coordination energy between amino acids and Eu3+, providing a strategy for the design of luminescent materials with tuneable chiroptical characteristics.

3.4. Lanthanide-derived mechanically interlocked molecules

Mechanically interlocked molecules (MIMs) have attracted great interest for chemists in the last decades.278 The formation of MIMs involves two or more interlocked molecules, so they cannot be separated without breaking the covalent bonds.279 Since there are several recent reviews focused on MIMs,21,225,280–287 in this section we will only discuss the latest examples of MIMs derived from lanthanide ions and nitrogen-donor ligands.

The first example of Ln-templated MIM was that of Gunnlaugsson and Lincheneau who in 2014 reported the formation of the [2] and [3]-catenanes using Eu3+, and ring closing metathesis reactions, the ligand being based on the dpa motif. While not being able to obtain the crystal structures of these MIMs, the authors used both HRMS and luminescence titrations to demonstrate their formation, where the ion was placed within the closely packed dpa macrocyles.288 Since then, only a relatively few examples of lanthanide-based MIMs have been reported.

In 2019 Ghosh and colleagues289 reported the synthesis of a phenanthroline-based macrocycle 97 together with an alkene-terminated ligand 98 to achieve a multifunctional [2]catenane (Fig. 48), with the ability to bind Eu3+ and Gd3+ ions inside the supramolecular architecture. The experimental studies demonstrated that both lanthanide ions were coordinated within the host cavity, as shown by HRMS, and the authors obtained the X-ray crystal structure of Eu-[2]catenane.


image file: d5cs00750j-f48.tif
Fig. 48 Lanthanide-binding [2]catenane.289 Adapted from ref. 289 with permission from the Royal Society of Chemistry, Copyright©2019.

Thompson and co-workers developed a series of five polyrotaxanes derived from different cyclodextrins (Fig. 49) modified with the chelating agent 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) to improve the coordination of Gd3+ ions within the cavity.


image file: d5cs00750j-f49.tif
Fig. 49 Structural formulas of the ligands used for the synthesis of polyrotaxanes (99–101).290

This study focuses on the evaluation of the physicochemical and imaging properties of these rotaxanes, which display high stability, high relaxivity as MRI contrast agents, and biocompatibility.290

Recently, Schaufelberger and coworkers have reported how mechanical bonds can modulate lanthanide luminescence in [2]rotaxanes, providing efficient energy transfer and selectivity towards Cu2+ ions, acting as efficient turn-off sensors, opening a new path of bioresponsive probes and imaging applications.292

Many studies focused on molecular knots with d-metal ions have been published in the last few years.293–296 In contrast, the use of lanthanides is less common, but this area has been pioneered by Leigh et al. The Leigh research group was the first in demonstrating the use of the Ln-ions in knot formation, and have since then, made significant efforts by studying these topologies using lanthanide ions.297

The design of the molecules builds on the “Trinity Sliotar” family motif derived by the Gunnlaugsson group, using the dpa ligands with (R)- or (S)-1-(2-naphthyl)ethylamine antennae.137

For example, in 2018, the Leigh group reported a rotaxane-like structure, Lu-102–103, obtained by tying a knot by means of lanthanide-templated synthesis. This knotting increases the steric hindrance locking a macrocycle on the thread (Fig. 50), and they observed that while removing the Lu3+ ion, the knot unties and the macrocycle de-threads, demonstrating that this process is reversible by introducing Lu3+ again.291


image file: d5cs00750j-f50.tif
Fig. 50 Structural formulas of the ligands used to obtain the rotaxane-like structure Lu-102–103.291

To further explore this field, the Leigh group studied the stereoselective synthesis of knots with different topologies (e.g. square and granny knots) through lanthanide-templated synthesis. To achieve this, they synthesized two different tris(2,6-pyridinedicarboxamide) ligands, resulting in enantiomeric granny knots and in a diastereomeric square knot.298

In a related study, Leigh et al. found that variation in the metal ion used to tie the knot can give rise to different knots using the same strand. Thus, the metal ion used can guide the folding and entanglement of the knot in the same way as chaperones during the protein folding.33

Furthermore, they synthesised three different Lu3+-derived knots using the chiral ligands 104–106 (Fig. 51). This study has elucidated the ability of these knots to induce a twist in an achiral liquid crystal. Therefore, this modifies the pitch and inverts the chirality of the liquid crystal, modifying its macroscopic properties.299


image file: d5cs00750j-f51.tif
Fig. 51 Structural formulas of the ligands 104–106 and representation of the derived knots.299 Adapted from ref. 299 with permission from Springer Nature, Copyright©2020.

In 2022, the Leigh group introduced a new approach for the synthesis of molecular knots using a Vernier template synthesis. This strategy employs coordinatively mismatching ligands and lanthanide metal ions, being more effective than the use of metal helicates to cross the strands and prepare the knots.

The Vernier approach allowed the authors to obtain specific knots with a better yield. It also allowed them to gain control over their topology by modifying the L/M ratio, hence enabling the synthesis of more complex knots and, thereby, showing specific structure and functional properties.300 These knots also showed enhanced stability and different chiroptical properties. Additionally, the synthesised dpa or 2,6-pyridinedicarboxamide (pdc)-derived achiral and chiral ligands were described as precursors of different molecular knots. By means of pdc-Lu3+ social self-sorting, a derived trefoil knot was obtained by using achiral ligands in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 stoichiometry, while granny and square knots were achieved using chiral ligands.301

These findings further highlight the importance of the ligand design in guiding the self-assembly of molecular knots. From this short account, it is clear that the lanthanides can play a major role in the formation of supramolecular self-assembly-based MIM systems, an area that is only just beginning to be explored for such systems.

3.5. Metallo-supramolecular polymers

Metallo-supramolecular polymers featuring Ln3+ ions have emerged as promising systems for the development of gels and soft materials with improved mechanical and luminescence properties. This type of supramolecular architecture demonstrates great potential for applications in materials science, where the coordination and the range of physical properties of the lanthanides can be truly capitalised on. As several reviews have been published recently, covering all the aspects about this type of architecture, this section will only discuss the recent advancements, where the systems formed have been done so with the view of capitalising on their luminescence properties.76,77,302,303

Several pyridine-based metallo-supramolecular polymers with different polycarbonate backbones BEP (pyridine-2,6-bis(ethyl)ester) and BDP (pyridine-2,6-bis(diethylamide)) have been recently synthesised for such polymer formation. Upon coordination with Ln3+ ions (Ln = Eu and Tb), the resulting polymers exhibited an increase in glass transition temperatures and Ln3+-centred emissions (Fig. 52).


image file: d5cs00750j-f52.tif
Fig. 52 Polycarbonate backbones BEP and BDP.304

The BEP polymer showed higher emission efficiencies for both Eu3+ and Tb3+ polymer systems, compared with the BDP-derived systems. Furthermore, a blue emission was observed when Tb3+ was used, and a white light emission was achieved by the Eu1.8Tb28(BEP)1 system. This type of functional materials can be used in multicolour displays or in combination for white light generation.304

The synthesis of metallosupramolecular multiblock copolymers using Eu3+ and Tb3+ complexes as building blocks (Fig. 53) was successfully achieved by a seeded living polymerization technique. Two different aggregates were developed from the Eu3+ complexes: the kinetic spheric aggregate rises from the [Eu(107(R,R))(NO3)3] complex (1[thin space (1/6-em)]:[thin space (1/6-em)]1), and the thermodynamic fibre aggregate rises from the [Eu2(107(R,R))(NO3)6] complex (2[thin space (1/6-em)]:[thin space (1/6-em)]1) via π–π stacking and hydrogen bond formation. The polymerization of [Eu2(107(NO3)6] was kinetically controlled by changing the concentration of the metallic salt. This resulted in a metallosupramolecular polymer with controlled length. By means of copolymerizing the kinetically formed Tb3+ complex with a seed derived from the Eu3+ complex, they developed metallosupramolecular tri- and penta-block copolymers via a seed-end chain-growth mechanism. [Eu(108(R))] was also successfully used as a seed to obtain tri-block copolymers.305


image file: d5cs00750j-f53.tif
Fig. 53 Terpyridine-based ligands 107 and 108.305

Lately, a new route to obtain polymer hydrogels that are highly stretchable and luminescent with magnetic resonance relaxation properties was developed by using a small amount of lanthanide-derived cages as cross-linkers. To achieve this, the ligand 109 (Fig. 54) was synthesised and coordinated to Eu3+ and/or Gd3+ ions to form the cages [K24Ln8(109)12].


image file: d5cs00750j-f54.tif
Fig. 54 Structural formula of ligand 109.306

After this, the cages were used as cross-linkers for the free radical polymerization with acrylamide, to obtain polymeric hydrogels. The hydrogels exhibited superior stretchability and tensile stress, strong luminescence in the case of Eu3+-derived hydrogels and efficient magnetic resonance relaxation properties for Gd3+-derived hydrogels. Notably, both ions could co-assemble with the ligand 109, giving rise to the [K24EuxGd8−x(109)12] cage offering potential applications in biomedical imaging.306

Piguet and co-workers have recently reported the synthesis of the ligands 110–115 assisted by metal ions (Fig. 55), with the aim of modulating the luminescence properties of the corresponding Eu3+ complexes.307 Their investigation revealed that a dimer 114 and a polymer 115, both derived from ligand 110, were obtained through the acyclic diene metathesis polymerization (ADMET), an essential methodology in the design of polymer architectures in supramolecular chemistry.


image file: d5cs00750j-f55.tif
Fig. 55 Structural formulas of ligands 110–115.307

However, it was found that the Ru-based Grubbs catalyst activity was hindered by the coordination of 110 to [Eu(hfac)3], preventing an efficient polymerisation, thus precoordination with [Eu(hfac)3] was achieved before polymerisation, guaranteeing the success of the reaction. The resulting dimer 114 and polymer 115 exhibited extended π-conjugation, where the number of conjugated π-electrons in the ligand has crucial influence on the luminescence properties of the derived Eu3+ complexes. It was observed that the ligand-sensitised photoluminescence quantum yields for Eu3+ complexes decreased with the extension of π-conjugation due to quenching through unfavourable europium-to-ligand back energy transfers [Eu(113)(hfac)3 > Eu(112)(hfac)3 > Eu(111)(hfac)3 > Eu(110)(hfac)3 > Eu2(114)(hfac)6 > Eu18(115)18(hfac)54].307

Gunnlaugsson and co-workers have also explored the field of lanthanide-based/crosslinked metallosupramolecular polymers. For example, they developed the btp ligands 116–118 (Fig. 56) by incorporating a methyacrylamide unit in these structures, with the aim of obtaining polymeric hydrogels.308


image file: d5cs00750j-f56.tif
Fig. 56 Structural formulas of btp-derived ligands 116–118.308,309

Compound 118 was made with the intention to be incorporated into a polymeric film using 2-hydroxyethyl methacrylate (HEMA), ethylene glycol dimethacrylate (EGDMA) and methylmethacrylate (MMA), while 117 was used as a ‘model compound’ to compare how the incorporation of 118 into a polymeric backbone affects its photophysical properties upon Ln3+ coordination. The Tb(117)3 complex showed long lifetimes and a high quantum yield in solutions (Φ = 72%). A fiber supramolecular hydrogel was also developed upon interactions of 116 with Tb3+.

Two luminescent polymers were developed in this work, showing metal ion-mediated cross-linking upon interaction with Ln3+. These materials also showed no metal leakage after long-term water exposure, showing that the Tb3+ emission was stable over a long period of time. Furthermore, the hydrogels remain highly luminescent in aqueous media, indicating no dissociation, which is a significant improvement over the previous system. This work is ongoing using the ligands incorporating conjugated receptor sites to develop responsive polymers for use in luminescence sensing applications.308

To further explore the use of the btp ligands in such material chemistry, Gunnlaugsson and co-workers employed ligand 116 combined with poly(ethylene-alt-maleic anhydride)[P(E-alt-MA)] as a precursor of two polymers that are soluble in water and methanol (P1 and P2). The resulting cross-linked polymers coordinated to the Tb3+ ions showed strong green luminescence, which was clearly visible to the naked eye.309

The results of the titration studies, where the interaction between the btp ligands upon gradual addition of Tb3+ revealed the predominant formation of 1[thin space (1/6-em)]:[thin space (1/6-em)]2 (M[thin space (1/6-em)]:[thin space (1/6-em)]L) species in solution, suggested that two ligands from the polymer backbone can coordinate to one Tb3+ ion, enabling cross-linking. However, within the polymer structures, other stoichiometries could also occur; this is more difficult to quantify vs. that done in solutions for such btp-based ligands. In this system the backbone itself most likely also plays an important role in coordinating to metal ions.309

Following their previous work with chiral naphthyl-derived ligands, the Gunnlaugsson group also synthesised Eu3+ complexes derived from the monotopic asymmetric dpa ligand 119 and the symmetric dpa ligand 120 (Fig. 57), with the aim of studying how the symmetry of the ligand affects the properties of the resulting hydrogels, and how this was translated into the polymer photophysical properties.


image file: d5cs00750j-f57.tif
Fig. 57 (A) Structural formulas of 119(R), 119(S), 120(R,R) and 120(S,S) and normalised time-gated emission spectra of (B) p(HEMA-co-EGDMA-co-120(S,S)) and (C) p(HEMA-co-EGDMA-co-119(S)) hydrogels that swelled in the presence of 0.33 equiv. of Eu3+ (red line) and the corresponding dehydrated gel (blue line). Insets represent the photographs of the corresponding materials swelled in the presence of Eu3+ under ambient and UV light.310 Adapted from ref. 310 with permission from the Royal Society of Chemistry, Copyright©2019.

These two monomers were employed in the co-polymerisation to form supramolecular hydrogels, where the lanthanide ion acts as a crosslinking agent enabling Eu3+-centred luminescence of the resulting material.310 These monomers were incorporated as additional crosslinkers in HEMA-based hydrogels. The authors demonstrated that in the case of the asymmetric ligand 119(S), the dominant stoichiometry within the polymer was found to be Eu(119)2, resulting in less emissive materials. In contrast, the hydrogel derived from the ligand 120(R,R) revealed the formation of more stable Eu(120)3 with a higher red luminescence intensity, which was clearly visible to the naked eye. These findings demonstrate the role of the ligand design on the final photophysical properties of lanthanide-derived hydrogels.

Kotova et al. have recently designed and utilised compound 121 (Fig. 58), a mannose-derived dpa ligand conjugated to K+-stabilised guanosine quadruplexes (G4), with the aim of developing bio-inspired healable luminescent hydrogels using Eu3+ ions.311


image file: d5cs00750j-f58.tif
Fig. 58 (A) Structural formula of 121 and the schematic of the guanosine quadruplexes (G4) functionalised with 121 (G4-121) comprising the hydrogel. The binding site of Eu3+ ion is depicted schematically. (B) and (C) SEM images of dried hydrogel G4-121.311 Adapted from ref. 311 with permission from Elsevier B.V., Copyright©2022.

In this study, hydrogels of G4-121 were prepared in a 1/1 ratio (121[thin space (1/6-em)]:[thin space (1/6-em)]Eu3+), resulting in materials with Eu3+-centred CPL emissions. The authors also explored rheological and morphological properties of the hydrogels (Fig. 58). This study is particularly relevant in view of exploring and understanding the mechanisms of induced CPL and the recent discovery of the biological activity of lanthanide ions, as these gels could be used as models for studying biological processes.

Following the line of the studies incorporating biologically related molecules, a series of tripodal ligands containing amino acids were developed using the benzene-1,3,5-tricarboxamide (BTA) motif, 122–125 (Fig. 59A).


image file: d5cs00750j-f59.tif
Fig. 59 (A) Structural formulas of the ligands 122–125. (B) SEM image of the xerogels formed from 122. (C) SEM image of the microspheres formed from 123.312 Adapted from ref. 312 with permission from Elsevier B.V., Copyright©2024.

The developed molecules showed the formation of self-assembly structures with different morphologies. For example, the glycine derivative of the ligand 122 assembles in a robust gel (Fig. 59(B)), whereas monodisperse solid microspheres were obtained in the cases of alanine-, phenylalanine- and leucine-derived ligands (Fig. 59(C)). The addition of Eu3+ and Tb3+ ions resulted in further morphological changes of the ligand assemblies: from a fibrous gel to nanospheres in the case of glycine derivatives, while in the other cases, hierarchical crosslinked superstructures were formed. Notably, the inherent chirality of the self-assemblies influences the chirality of the microspheres functionalised with lanthanide ions, resulting in CPL.312

Lately, the Gunnlaugsson group have further reported the use of tripodal BTA-derived ligands functionalized with terpyridine units acting as a low-molecular weight gelator (LMWG) molecules forming supramolecular gels. They found that these ligands 126 and 127 (Fig. 60) form gels in different organic solvents, and that upon addition of d- or f-metal ions, the cross-linking of the gel fibres occurred, leading to modified morphological and rheological properties of the gels while bringing the photophysical functionality to the newly formed system.313,314


image file: d5cs00750j-f60.tif
Fig. 60 (A) Structural formulas of ligands 126 and 127; SEM images of organogel (B) 126 (0.6 wt%), and its corresponding metallogels with (C) La3+ and (D) Sm3+. Adapted from references (CC-BY-4.0).313,314 Adapted from ref. 313 and 314 with permission from Wiley-VCH, Copyright©2025.

One of the latest examples of fluorescent hydrogels was developed by Liao and colleagues via a one-pot synthetic methodology, combining a red-light-emitting dpa-derived Eu3+ complex Eu(dpa)3, together with a blue light-emitting AIE molecule.

These molecules were introduced into a poly(vinyl alcohol) (PVA) hydrogel to obtain a multicolour tuneable fluorescence hydrogel. The resulting hydrogel exhibited stimuli response to different changes, such as pH, excitation wavelength or the presence of Fe3+ ions (Fig. 61). This approach opens a new path for the design and synthesis of novel multifunctional materials.315


image file: d5cs00750j-f61.tif
Fig. 61 PVA hydrogels containing Eu(dpa)3 and blue-emitting AIE molecule at acidic and basic pH under daylight or a 254/365 nm excitation source. Adapted from reference.315 Adapted from ref. 315 with permission from the American Chemical Society, Copyright©2025.

4. Conclusions and future perspectives

The development of novel lanthanide-derived self-assemblies has increased in the last few years, driven by the interesting luminescence properties and potential applications of these systems. Of particular interest is understanding how these self-assemblies are formed, thus controlling the factors that have influence on the final stoichiometry, architecture and properties of the resulting lanthanide complexes has become the focus of research to date. Herein, we provided an update and comprehensive overview of luminescent lanthanide self-assemblies derived from non-macrocyclic nitrogen-donor ligands, covering studies reported from 2017 to date. All these systems show promising properties including temperature- or pH-dependent luminescence, upconversion, circularly polarized luminescence or biological activity. These properties highlight their potential for different applications of such self-assemblies as smart supramolecular materials: pH- or temperature-sensors, biological probes for use in sensing, imaging or diagnosis, optical sensors, switchable molecules or luminescent plastic materials.

Despite the aforementioned advancements, there remains much to explore within this field of research. One particularly fascinating area for future research is the exploration of their biological and bio-materials properties.316–319 For instance, lanthanides have been shown to play an important role in bacterial metabolism,316 as demonstrated by the finding of a lanthanide-binding molecule produced by Methylobacterium extorquens. This discovery provides insights into how microbes interact and sense lanthanide ions.319 New insights into the potential of gadolinium-derived complexes as promising contrast agents were also reported.320 Moreover, as the use of lanthanides increases, the toxicity of lanthanides emerges as an important topic of investigation. Lately, different novel functional genomics techniques have been used to identify potential therapeutic targets to mitigate the toxic effects of lanthanides.321

Additionally, the urgent need to recover lanthanides by using chelating ligands is another area to be explored, as lanthanides are essential in everyday technological materials.322–327 Recently, the development of 2D protein layers as chelating agents for lanthanide ions has been reported, representing a promising approach for their recovery.325 It is very likely that supramolecular self-assembly structures from lanthanides can also be used for such applications.

While some of the examples presented herein have demonstrated some selectively of one lanthanide ion over the other, their efficient separation remains a challenge due to their chemical similarity.328,329 Recently, a machine learning approach has been developed to predict lanthanide extraction behaviour, screening a large number of ligands for accurate separation.330 Once again, the idea of ‘selective lanthanide’ self-assembly can be employed to distinguish between such closely related ions! Some progress has been made on this, as the synthesis of a two-ligand system combining lipophilic and hydrophilic behaviours with opposing Ln selectivity has recently been reported, leading to the selective separation of lanthanide ions.331 Similarly, modifications in the connectivity and preorganization of tetradentate [N2O2] ligands have demonstrated changes in their selectivity for lanthanide ions.332

With all these in mind, these challenges open the possibility to continue exploring within the field of lanthanide self-assemblies, providing new knowledge, advancements and interesting applications. It is clear that the future of supramolecular lanthanide chemistry is very bright, and we hope that this review, in addition to giving an overview of the recent progress in the area, can be an inspiration to newcomers to the field to tackle such challenges with new views and ideas, where the lanthanides take on a central role in supramolecular self-assembly chemistry.

Author contributions

All the authors took part in reviewing the area, gathering information and examples from the literature and writing this manuscript. S. F-F. is the lead writer of this review, supervised the writing along with S. O. D. and O. K. and edited the first draft. T. G. supervised the project and edited the final draft of the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

No primary research results, software or code have been included, and no new data were generated or analysed as part of this review.

Acknowledgements

We would like to thank the Irish Research Council (IRC Postgraduate funding to S.D. GOIPG/2018/2993) and Xunta de Galicia for the postdoctoral fellowship (S.F.-F. Ref. ED481B_044/2024). TG would like to thank Science Foundation Ireland (SFI, now renamed Research Ireland) and the SFI Synthesis and Solid-State Pharmaceutical Center (SSPC) for Research Centres Phase 2 Funding (12/RC/2275_P2).

Notes and references

  1. J.-M. Lehn, Angew. Chem., Int. Ed. Engl., 1988, 27, 89–112 Search PubMed.
  2. C. J. Pedersen, Angew. Chem., Int. Ed. Engl., 1988, 27, 1021–1027 Search PubMed.
  3. D. J. Cram, Angew. Chem., Int. Ed. Engl., 1988, 27, 1009–1112 Search PubMed.
  4. J. Sauvage, Angew. Chem., Int. Ed., 2017, 56, 1–15 Search PubMed.
  5. J. F. Stoddart, Angew. Chem., Int. Ed., 2017, 56, 2–34 Search PubMed.
  6. B. L. Feringa, Angew. Chem., Int. Ed., 2017, 56, 1–20 Search PubMed.
  7. S. Thoonen, K. L. Tuck and D. R. Turner, Coord. Chem. Rev., 2025, 522, 216203 Search PubMed.
  8. J. C. G. Bünzli and C. Piguet, Chem. Soc. Rev., 2005, 34, 1048–1077 Search PubMed.
  9. J. L. Greenfield and J. R. Nitschke, Acc. Chem. Res., 2022, 55, 391–401 Search PubMed.
  10. R. Chakrabarty, P. S. Mukherjee and P. J. Stang, Chem. Rev., 2011, 111, 6810–6918 Search PubMed.
  11. C. Piguet, M. Borkovec, J. Hamacek and K. Zeckert, Coord. Chem. Rev., 2005, 249, 705–726 Search PubMed.
  12. A. P. Paneerselvam, S. S. Mishra and D. K. Chand, J. Chem. Sci., 2018, 130, 96 Search PubMed.
  13. M. Albrecht, Chem. Rev., 2001, 101, 3457–3497 Search PubMed.
  14. E. G. Percástegui, T. K. Ronson and J. R. Nitschke, Chem. Rev., 2020, 120, 13480–13544 Search PubMed.
  15. A. J. McConnell, Chem. Soc. Rev., 2022, 51, 2957–2971 Search PubMed.
  16. X. Wang, Y. Jiang, A. Tissot and C. Serre, Coord. Chem. Rev., 2023, 497, 215454 Search PubMed.
  17. Y. Zhang, S. Liu, Z. S. Zhao, Z. Wang, R. Zhang, L. Liu and Z. B. Han, Inorg. Chem. Front., 2021, 8, 590–619 Search PubMed.
  18. J. L. Obeso, C. V. Flores, R. A. Peralta, M. Viniegra, N. Martín-Guaregua, M. T. Huxley, D. Solis-Ibarra, I. A. Ibarra and C. Janiak, Chem. Soc. Rev., 2025, 54, 4135–4163 Search PubMed.
  19. S. Sahoo, S. Mondal and D. Sarma, Coord. Chem. Rev., 2022, 470, 214707 Search PubMed.
  20. G. Gil-Ramírez, D. A. Leigh and A. J. Stephens, Angew. Chem., Int. Ed., 2015, 127, 6208–6249 Search PubMed.
  21. E. M. G. Jamieson, F. Modicom and S. M. Goldup, Chem. Soc. Rev., 2018, 47, 5266–5311 Search PubMed.
  22. V. N. Vukotic and S. J. Loeb, Chem. Soc. Rev., 2012, 41, 5896–5906 Search PubMed.
  23. H. Y. Zhou, Q. S. Zong, Y. Han and C. F. Chen, Chem. Commun., 2020, 56, 9916–9936 Search PubMed.
  24. Z. Ashbridge, S. D. P. Fielden, D. A. Leigh, L. Pirvu, F. Schaufelberger and L. Zhang, Chem. Soc. Rev., 2022, 51, 7779–7809 Search PubMed.
  25. O. Lukin and F. Vögtle, Angew. Chem., Int. Ed., 2005, 44, 1456–1477 Search PubMed.
  26. J. F. Ayme, J. E. Beves, C. J. Campbell and D. A. Leigh, Chem. Soc. Rev., 2013, 42, 1700–1712 Search PubMed.
  27. S. D. P. Fielden, D. A. Leigh and S. L. Woltering, Angew. Chem., Int. Ed., 2017, 56, 11166–11194 Search PubMed.
  28. S. Panja and D. J. Adams, Chem. Soc. Rev., 2021, 50, 5165–5200 Search PubMed.
  29. B. C. Roy, A. Kundu, P. Biswas, S. Roy and T. S. Mahapatra, ChemistrySelect, 2024, 9, e202304755 Search PubMed.
  30. W. W. Qin, B. F. Long, Z. H. Zhu, H. L. Wang, F. P. Liang and H. H. Zou, Dalton Trans., 2024, 53, 3675–3684 Search PubMed.
  31. M. I. Bardot, C. W. Weyhrich, Z. Shi, M. Traxler, C. L. Stern, J. Cui, D. A. Muller, M. L. Becker and W. R. Dichtel, Science, 2025, 387, 264–269 Search PubMed.
  32. J. H. May, J. M. Fehr, J. C. Lorenz, L. N. Zakharov and R. Jasti, Angew. Chem., Int. Ed., 2024, 63, e202401823 Search PubMed.
  33. D. A. Leigh, F. Schaufelberger, L. Pirvu, J. H. Stenlid, D. P. August and J. Segard, Nature, 2020, 584, 562–568 Search PubMed.
  34. K. M. Bąk, B. Trzaskowski and M. J. Chmielewski, Chem. Sci., 2024, 15, 1796–1809 Search PubMed.
  35. M. Zhang, S. Chen and L. Zhang, J. Chem. Ed., 2025, 102, 338–347 Search PubMed.
  36. M. Cirulli, A. Kaur, J. E. M. Lewis, Z. Zhang, J. A. Kitchen, S. M. Goldup and M. M. Roessler, J. Am. Chem. Soc., 2019, 141, 879–889 Search PubMed.
  37. S. Bernhard and M. W. Tibbitt, Adv. Drug Delivery Rev., 2021, 171, 240–256 Search PubMed.
  38. M. J. Webber and R. Langer, Chem. Soc. Rev., 2017, 46, 6600–6620 Search PubMed.
  39. H. Xu, R. Chen, Q. Sun, W. Lai, Q. Su, W. Huang and X. Liu, Chem. Soc. Rev., 2014, 43, 3259–3302 Search PubMed.
  40. H. Chen and J. Fraser Stoddart, Nat. Rev. Mater., 2021, 6, 804–828 Search PubMed.
  41. M. Kataria and S. Seki, Chem. – Eur. J., 2025, 31, e202403460 Search PubMed.
  42. A. Pöthig and A. Casini, Theranostics, 2019, 9, 3150–3169 Search PubMed.
  43. I. V. Kolesnichenko and E. V. Anslyn, Chem. Soc. Rev., 2017, 46, 2385–2390 Search PubMed.
  44. C. Alexander, Z. Guo, P. B. Glover, S. Faulkner and Z. Pikramenou, Chem. Rev., 2025, 125, 2269–2370 Search PubMed.
  45. T. L. Mako, J. M. Racicot and M. Levine, Chem. Rev., 2019, 119, 322–477 Search PubMed.
  46. D. Wu, A. C. Sedgwick, T. Gunnlaugsson, E. U. Akkaya, J. Yoon and T. D. James, Chem. Soc. Rev., 2017, 46, 7105–7123 Search PubMed.
  47. G. Moreno-Alcántar, M. Drexler and A. Casini, Nat. Rev. Chem., 2024, 8, 893–914 Search PubMed.
  48. M. V. Ramakrishnam Raju, S. M. Harris and V. C. Pierre, Chem. Soc. Rev., 2020, 49, 1090–1108 Search PubMed.
  49. S. J. Butler and D. Parker, Chem. Soc. Rev., 2013, 42, 1652–1666 Search PubMed.
  50. S. E. Bodman and S. J. Butler, Chem. Sci., 2021, 12, 2716–2734 Search PubMed.
  51. E. Yashima, N. Ousaka, D. Taura, K. Shimomura, T. Ikai and K. Maeda, Chem. Rev., 2016, 116, 13752–13990 Search PubMed.
  52. A. V. Virovets, E. Peresypkina and M. Scheer, Chem. Rev., 2021, 121, 14485–14554 Search PubMed.
  53. L. J. Chen, H. B. Yang and M. Shionoya, Chem. Soc. Rev., 2017, 46, 2555–2576 Search PubMed.
  54. V. V. Utochnikova, Coord. Chem. Rev., 2019, 398, 113006 Search PubMed.
  55. W. Thor, A. N. Carneiro Neto, R. T. Moura, K. L. Wong and P. A. Tanner, Coord. Chem. Rev., 2024, 517, 215927 Search PubMed.
  56. S. Pullen, J. Tessarolo and G. H. Clever, Chem. Sci., 2021, 12, 7269–7293 Search PubMed.
  57. X. Z. Li, C. Bin Tian and Q. F. Sun, Chem. Rev., 2022, 122, 6374–6458 Search PubMed.
  58. M. Meyer, B. Kersting, R. E. Powers and K. N. Raymond, Inorg. Chem., 1997, 36, 5179–5191 Search PubMed.
  59. C. Piguet, A. F. Williams, G. Bernardiuelli, E. Moret and J.-C. G. Bünzli, Helv. Chim. Acta, 1992, 75, 1697 Search PubMed.
  60. M. Elhabiri, R. Scopelliti, J.-C. G. Bünzli and C. Piguet, Chem. Commun., 1998, 2347–2348 Search PubMed.
  61. N. M. Shavaleev, S. V. Eliseeva, R. Scopelliti and J. C. G. Bünzli, Inorg. Chem., 2015, 54, 9166–9173 Search PubMed.
  62. W. D. Horrocks and D. R. Sudnick, Acc. Chem. Res., 1981, 14, 384–392 Search PubMed.
  63. G. Bao, S. Wen, G. Lin, J. Yuan, J. Lin, K. L. Wong, J. C. G. Bünzli and D. Jin, Coord. Chem. Rev., 2021, 429, 213642 Search PubMed.
  64. Y. Zha, Z. Bian and Z. Liu, Polyhedron, 2025, 272, 117452 Search PubMed.
  65. Y. L. Li, H. L. Wang, Z. H. Zhu, Y. F. Wang, F. P. Liang and H. H. Zou, Nat. Commun., 2024, 15, 2896 Search PubMed.
  66. A. G. Bispo Jr, N. A. Oliveira, I. M. S. Diogenis and F. A. Sigoli, Coord. Chem. Rev., 2025, 523, 216279 Search PubMed.
  67. I. F. Costa, L. Blois, T. B. Paolini, I. P. Assunção, E. E. S. Teotonio, M. C. F. C. Felinto, R. T. Moura, R. L. Longo, W. M. Faustino, L. D. Carlos, O. L. Malta, A. N. Carneiro Neto and H. F. Brito, Coord. Chem. Rev., 2024, 502, 215590 Search PubMed.
  68. L. Llanos, P. Cancino, P. Mella, P. Fuentealba and D. Aravena, Coord. Chem. Rev., 2024, 505, 215675 Search PubMed.
  69. P. P. Ferreira da Rosa, Y. Kitagawa and Y. Hasegawa, Coord. Chem. Rev., 2020, 406, 213153 Search PubMed.
  70. O. G. Willis, F. Zinna and L. Di Bari, Angew. Chem., Int. Ed., 2023, 62, e202302358 Search PubMed.
  71. F. Pointillart, O. Cador, B. Le Guennic and L. Ouahab, Coord. Chem. Rev., 2017, 346, 150–175 Search PubMed.
  72. S. J. Bradberry, A. J. Savyasachi, M. Martinez-Calvo and T. Gunnlaugsson, Coord. Chem. Rev., 2014, 273–274, 226–241 Search PubMed.
  73. A. De Bettencourt-Dias, P. S. Barber and S. Viswanathan, Coord. Chem. Rev., 2014, 273–274, 165–200 Search PubMed.
  74. L. Su, X. Liu, Q. Niu and Z. Li, J. Mater. Chem. C, 2024, 12, 10759–10774 Search PubMed.
  75. D. E. Barry, D. F. Caffrey and T. Gunnlaugsson, Chem. Soc. Rev., 2016, 45, 3244–3274 Search PubMed.
  76. F. Ahmed, M. Muzammal Hussain, W. Ullah Khan and H. Xiong, Coord. Chem. Rev., 2024, 499, 215486 Search PubMed.
  77. D. Yang, H. Li and H. Li, Coord. Chem. Rev., 2024, 514, 215875 Search PubMed.
  78. J. C. G. Bünzli, Coord. Chem. Rev., 2015, 293–294, 19–47 Search PubMed.
  79. A. Beeby, I. M. Clarkson, R. S. Dickins, S. Faulkner, D. Parker, L. Royle, A. S. de Sousa, J. A. Gareth Williams and M. Woods, J. Chem. Soc., Perkin Trans. 2, 1999, 493–503 Search PubMed.
  80. E. A. Suturina, K. Mason, M. Botta, F. Carniato, I. Kuprov, N. F. Chilton, E. J. L. McInnes, M. Vonci and D. Parker, Dalton Trans., 2019, 48, 8400–8409 Search PubMed.
  81. L. B. Jennings, S. Shuvaev, M. A. Fox, R. Pal and D. Parker, Dalton Trans., 2018, 47, 16145–16154 Search PubMed.
  82. A. C. Harnden, E. A. Suturina, A. S. Batsanov, P. K. Senanayake, M. A. Fox, K. Mason, M. Vonci, E. J. L. McInnes, N. F. Chilton and D. Parker, Angew. Chem., Int. Ed., 2019, 131, 10396–10400 Search PubMed.
  83. A. T. Frawley, H. V. Linford, M. Starck, R. Pal and D. Parker, Chem. Sci., 2018, 9, 1042–1049 Search PubMed.
  84. S. Shuvaev and D. Parker, Dalton Trans., 2019, 48, 4471–4473 Search PubMed.
  85. E. R. H. Walter, J. A. G. Williams and D. Parker, Chem. Commun., 2017, 53, 13344–13347 Search PubMed.
  86. S. Shuvaev, M. A. Fox and D. Parker, Angew. Chem., Int. Ed., 2018, 57, 7488–7492 Search PubMed.
  87. J. D. Fradgley, M. Starck, M. Laget, E. Bourrier, E. Dupuis, L. Lamarque, E. Trinquet, J. M. Zwier and D. Parker, Chem. Commun., 2021, 57, 5814–5817 Search PubMed.
  88. M. Starck, J. D. Fradgley, R. Pal, J. M. Zwier, L. Lamarque and D. Parker, Chem. – Eur. J., 2021, 27, 766–777 Search PubMed.
  89. Y. Zhang, X. Ma, H. F. Chau, W. Thor, L. Jiang, S. Zha, W. Y. Fok, H. N. Mak, J. Zhang, J. Cai, C. F. Ng, H. Li, D. Parker, L. Li, G. L. Law and K. L. Wong, ACS Appl. Nano Mater., 2021, 4, 271–278 Search PubMed.
  90. D. F. De Rosa, M. Starck, D. Parker and R. Pal, Chem. – Eur. J., 2024, 30, e202303227 Search PubMed.
  91. D. Parker, J. D. Fradgley and K. L. Wong, Chem. Soc. Rev., 2021, 50, 8193–8213 Search PubMed.
  92. K. Binnemans, Coord. Chem. Rev., 2015, 295, 1–45 Search PubMed.
  93. S. V. Eliseeva and J. C. G. Bünzli, Chem. Soc. Rev., 2010, 39, 189–227 Search PubMed.
  94. J.-C. G. Bünzli and S. V. Eliseeva, in Lanthanide Luminescence: Photophysical, Analytical and Biological Aspects, ed. P. Hanninen and H. Harma, Springer-Verlag, Berlin Heidelberg, 2010, pp. 1–45 Search PubMed.
  95. Y. Hasegawa, Y. Wada and S. Yanagida, J. Photochem. Photobiol., C, 2004, 5, 183–202 Search PubMed.
  96. M. Hasegawa, H. Ohmagari, H. Tanaka and K. Machida, J. Photochem. Photobiol., C, 2022, 50, 100484 Search PubMed.
  97. W. Thor, H. Y. Kai, Y. H. Yeung, Y. Wu, T. L. Cheung, L. K. B. Tam, Y. Zhang, L. J. Charbonnière, P. A. Tanner and K. L. Wong, JACS Au, 2024, 4, 3813–3822 Search PubMed.
  98. A. K. R. Junker, L. R. Hill, A. L. Thompson, S. Faulkner and T. J. Sørensen, Dalton Trans., 2018, 47, 4794–4803 Search PubMed.
  99. W. Thor, Y. Zhang, K. L. Wong and P. A. Tanner, Chem. Commun., 2021, 57, 10727–10730 Search PubMed.
  100. E. Kasprzycka, A. N. Carneiro Neto, V. A. Trush, O. L. Malta, L. Jerzykiewicz, V. M. Amirkhanov, J. Legendziewicz and P. Gawryszewska, Spectrochim. Acta, Part A, 2022, 274, 121072 Search PubMed.
  101. V. R. M. Nielsen, P. R. Nawrocki and T. J. Sørensen, J. Phys. Chem. A, 2023, 127, 3577–3590 Search PubMed.
  102. V. R. M. Nielsen, M. Grasser, B. Le Guennic and T. J. Sørrensen, Inorg. Chem., 2025, 64, 3463–3475 Search PubMed.
  103. S. S. Mortensen, M. A. Marciniak Nielsen, P. Nawrocki and T. J. Sørensen, J. Phys. Chem. A, 2022, 126, 8596–8605 Search PubMed.
  104. P. R. Nawrocki and T. J. Sørensen, Phys. Chem. Chem. Phys., 2023, 25, 19300–19336 Search PubMed.
  105. S. S. Mortensen, V. R. M. Nielsen and T. J. Sørensen, Dalton Trans., 2024, 53, 10079–10092 Search PubMed.
  106. N. Kofod, R. Arppe-Tabbara and T. J. Sørensen, J. Phys. Chem. A, 2019, 123, 2734–2744 Search PubMed.
  107. M. Storm Thomsen, A. S. Anker, L. Kacenauskaite and T. J. Sørensen, Dalton Trans., 2022, 51, 8960–8963 Search PubMed.
  108. V. R. M. Nielsen, M. Grasser, S. S. Mortensen, B. Le Guennic and T. J. Sørensen, Inorg. Chem., 2024, 63, 18596–18607 Search PubMed.
  109. V. R. M. Nielsen, B. Le Guennic and T. J. Sørensen, J. Phys. Chem. A, 2024, 128, 5740–5751 Search PubMed.
  110. N. Kofod and T. J. Sørensen, Dalton Trans., 2024, 53, 9741–9749 Search PubMed.
  111. Y. Zhang, W. Thor, K. L. Wong and P. A. Tanner, J. Phys. Chem. C, 2021, 125, 7022–7033 Search PubMed.
  112. N. Kofod, P. Nawrocki and T. J. Sørensen, J. Phys. Chem. Lett., 2022, 13, 3096–3104 Search PubMed.
  113. N. Kofod and T. J. Sørensen, J. Phys. Chem. Lett., 2022, 13, 11968–11973 Search PubMed.
  114. A. Ćirić, Ł. Marciniak and M. D. Dramićanin, Sci. Rep., 2022, 12, 563 Search PubMed.
  115. V. D. Savchenko, K. P. Zhuravlev and V. I. Tsaryuk, J. Lumin., 2024, 276, 120839 Search PubMed.
  116. S. Bej, X. Wang, J. Zhang, X. Yang and P. Ren, Coord. Chem. Rev., 2024, 513, 215862 Search PubMed.
  117. N. Wu, C. Bo and S. Guo, ACS Sens., 2024, 9, 4402–4434 Search PubMed.
  118. T. Gorai, W. Schmitt and T. Gunnlaugsson, Dalton Trans., 2021, 50, 770–784 Search PubMed.
  119. A. F. Henwood, I. N. Hegarty, E. P. McCarney, J. I. Lovitt, S. Donohoe and T. Gunnlaugsson, Coord. Chem. Rev., 2021, 449, 214206 Search PubMed.
  120. B. Golesorkhi, I. Taarit, H. Bolvin, H. Nozary, J. R. Jiménez, C. Besnard, L. Guénée, A. Fürstenberg and C. Piguet, Dalton Trans., 2021, 50, 7955–7968 Search PubMed.
  121. S. S. Mortensen and T. J. Sørensen, Eur. J. Inorg. Chem., 2023, e202300159 Search PubMed.
  122. L. Arrico, C. Benetti and L. Di Bari, ChemPhotoChem, 2021, 5, 815–821 Search PubMed.
  123. J. P. Byrne, J. A. Kitchen and T. Gunnlaugsson, Chem. Soc. Rev., 2014, 43, 5302–5325 Search PubMed.
  124. M. A. Halcrow, Coord. Chem. Rev., 2005, 249, 2880–2908 Search PubMed.
  125. H. Hofmeier and U. S. Schubert, Chem. Soc. Rev., 2004, 33, 373–399 Search PubMed.
  126. K. Tokunaga, Phys. Chem. Chem. Phys., 2009, 11, 1463–1473 Search PubMed.
  127. R. Carr, N. H. Evans and D. Parker, Chem. Soc. Rev., 2012, 41, 7673–7686 Search PubMed.
  128. A. Aebischer, F. Gumy and J. C. G. Bünzli, Phys. Chem. Chem. Phys., 2009, 11, 1346–1353 Search PubMed.
  129. S. E. Plush, N. A. Clear, J. P. Leonard, A. M. Fanning and T. Gunnlaugsson, Dalton Trans., 2010, 39, 3644–3652 Search PubMed.
  130. R. Shi, L. Yu, Y. Tian, X. Wang, Z. Sun, B. Qi and F. Luo, Mater. Chem. Phys., 2022, 280, 125806 Search PubMed.
  131. C. M. Balogh, I. N’Dala-Louika, I. Suleimanov, A. Pons, M. Jouffrieau, C. Camp, F. Chaput, L. Veyre, C. Thieuleux, O. Maury and F. Riobé, Adv. Opt. Mater., 2024, 12, 2400091 Search PubMed.
  132. X. S. Lin, Y. Yu, L. P. Zhou, L. He, T. Chen and Q. F. Sun, Dalton Trans., 2022, 51, 4836–4842 Search PubMed.
  133. O. Kotova, S. Blasco, B. Twamley, J. O’Brien, R. D. Peacock, J. A. Kitchen, M. Martínez-Calvo and T. Gunnlaugsson, Chem. Sci., 2015, 6, 457–471 Search PubMed.
  134. A. Galanti, O. Kotova, S. Blasco, C. J. Johnson, R. D. Peacock, S. Mills, J. J. Boland, M. Albrecht and T. Gunnlaugsson, Chem. – Eur. J., 2016, 22, 9709–9723 Search PubMed.
  135. C. Lincheneau, C. Destribats, D. E. Barry, J. A. Kitchen, R. D. Peacock and T. Gunnlaugsson, Dalton Trans., 2011, 40, 12005–12016 Search PubMed.
  136. J. P. Leonard, P. Jensen, T. McCabe, J. E. O’Brien, R. D. Peacock, P. E. Kruger and T. Gunnlaugsson, J. Am. Chem. Soc., 2007, 129, 10986–10987 Search PubMed.
  137. O. Kotova, J. A. Kitchen, C. Lincheneau, R. D. Peacock and T. Gunnlaugsson, Chem. – Eur. J., 2013, 19, 16181–16186 Search PubMed.
  138. H. Y. Wong, W. S. Lo, K. H. Yim and G. L. Law, Chem, 2019, 5, 3058–3095 Search PubMed.
  139. L. E. MacKenzie and R. Pal, Nat. Rev. Chem., 2021, 5, 109–124 Search PubMed.
  140. K. Staszak, K. Wieszczycka, V. Marturano and B. Tylkowski, Coord. Chem. Rev., 2019, 397, 76–90 Search PubMed.
  141. L. Llanos, P. Cancino, P. Mella, P. Fuentealba and D. Aravena, Coord. Chem. Rev., 2024, 505, 215675 Search PubMed.
  142. K. Taniguchi, M. Nishio, S. Kishiue, P. J. Huang, S. Kimura and H. Miyasaka, Phys. Rev. Mater., 2019, 3, 045202 Search PubMed.
  143. J. A. Kitchen, D. E. Barry, L. Mercs, M. Albrecht, R. D. Peacock and T. Gunnlaugsson, Angew. Chem., Int. Ed., 2012, 51, 704–708 Search PubMed.
  144. D. E. Barry, J. A. Kitchen, M. Albrecht, S. Faulkner and T. Gunnlaugsson, Langmuir, 2013, 29, 11506–11515 Search PubMed.
  145. D. E. Barry, J. A. Kitchen, L. Mercs, R. D. Peacock, M. Albrecht and T. Gunnlaugsson, Dalton Trans., 2019, 48, 11317–11325 Search PubMed.
  146. A. T. O’Neil, J. A. Harrison and J. A. Kitchen, Chem. Commun., 2021, 57, 8067–8070 Search PubMed.
  147. A. T. O’Neil, A. Chalard, J. Malmström and J. A. Kitchen, Dalton Trans., 2023, 52, 2255–2261 Search PubMed.
  148. S. J. Bradberry, A. J. Savyasachi, R. D. Peacock and T. Gunnlaugsson, Faraday Discuss., 2015, 185, 413–431 Search PubMed.
  149. D. F. Caffrey, T. Gorai, B. Rawson, M. Martínez-Calvo, J. A. Kitchen, N. S. Murray, O. Kotova, S. Comby, R. D. Peacock, P. Stachelek, R. Pal and T. Gunnlaugsson, Adv. Sci., 2024, 11, 2307448 Search PubMed.
  150. S. Di Pietro, D. Iacopini, A. Moscardini, R. Bizzarri, M. Pineschi, V. Di Bussolo and G. Signore, Molecules, 2021, 26, 1265 Search PubMed.
  151. M. Starck, L. E. Mackenzie, A. S. Batsanov, D. Parker and R. Pal, Chem. Commun., 2019, 55, 14115–14118 Search PubMed.
  152. K. R. Johnson and A. De Bettencourt-Dias, Inorg. Chem., 2019, 58, 13471–13480 Search PubMed.
  153. K. R. Johnson, S. B. Vittardi, M. A. Gracia-Nava, J. J. Rack and A. de Bettencourt-Dias, Chem. – Eur. J., 2020, 26, 7274–7280 Search PubMed.
  154. R. A. Tigaa, X. Aerken, A. Fuchs and A. de Bettencourt-Dias, Eur. J. Inorg. Chem., 2017, 5310–5317 Search PubMed.
  155. C. V. Rodrigues, K. R. Johnson, V. C. Lombardi, M. O. Rodrigues, J. A. Sobrinho and A. De Bettencourt-Dias, J. Med. Chem., 2021, 64, 7724–7734 Search PubMed.
  156. J. H. S. K. Monteiro, D. Machado, L. M. De Hollanda, M. Lancellotti, F. A. Sigoli and A. De Bettencourt-Dias, Chem. Commun., 2017, 53, 11818–11821 Search PubMed.
  157. J. H. S. K. Monteiro, N. R. Fetto, M. J. Tucker and A. De Bettencourt-Dias, Inorg. Chem., 2020, 59, 3193–3199 Search PubMed.
  158. J. H. S. K. Monteiro, N. R. Fetto, M. J. Tucker, F. A. Sigoli and A. de Bettencourt-Dias, J. Lumin., 2022, 245, 118768 Search PubMed.
  159. K. Wojtczak, E. Zahorska, I. J. Murphy, F. Koppel, G. Cooke, A. Titz and J. P. Byrne, Chem. Commun., 2023, 59, 8384–8387 Search PubMed.
  160. M. T. Phi, H. Singer, F. Zäh, C. Haisch, S. Schneider, H. J. M. Op den Camp and L. J. Daumann, ChemBioChem, 2024, 25, e202300811 Search PubMed.
  161. B. Jahn, A. Pol, H. Lumpe, T. R. M. Barends, A. Dietl, C. Hogendoorn, Huub J. M. Op Den Camp and L. J. Daumann, ChemBioChem, 2018, 19, 1147–1153 Search PubMed.
  162. K. Matsumoto, K. Suzuki, T. Tsukuda and T. Tsubomura, Inorg. Chem., 2010, 49, 4717–4719 Search PubMed.
  163. B. D. Ward and L. H. Gade, Chem. Commun., 2012, 48, 10587–10599 Search PubMed.
  164. J. Yuasa, T. Ohno, K. Miyata, H. Tsumatori, Y. Hasegawa and T. Kawai, J. Am. Chem. Soc., 2011, 133, 9892–9902 Search PubMed.
  165. K. Binnemans, Chem. Rev., 2009, 109, 4283–4374 Search PubMed.
  166. C. Freund, W. Porzio, U. Giovanella, F. Vignali, M. Pasini, S. Destri, A. Mech, S. Di Pietro, L. Di Bari and P. Mineo, Inorg. Chem., 2011, 50, 5417–5429 Search PubMed.
  167. D. Singh, S. Bhagwan, A. Dalal, K. Nehra, R. K. Saini, K. Singh, A. P. Simantilleke, S. Kumar and I. Singh, Rare Met., 2021, 40, 2873–2881 Search PubMed.
  168. I. M. S. Diogenis, A. G. Bispo-Jr, R. V. Pirovani, L. F. Saraiva, F. C. Gozzo, C. R. D. Correia, I. O. Mazali, R. A. Nome and F. A. Sigoli, J. Mater. Chem. C, 2024, 12, 5097–5107 Search PubMed.
  169. J. K. Clegg, F. Li and L. F. Lindoy, Coord. Chem. Rev., 2022, 455, 214355 Search PubMed.
  170. O. G. Willis, F. Petri, G. Pescitelli, A. Pucci, E. Cavalli, A. Mandoli, F. Zinna and L. Di Bari, Angew. Chem., Int. Ed., 2022, 61, e202208326 Search PubMed.
  171. M. Górecki, L. Carpita, L. Arrico, F. Zinna and L. Di Bari, Dalton Trans., 2018, 47, 7166–7177 Search PubMed.
  172. F. Zinna, L. Arrico and L. Di Bari, Chem. Commun., 2019, 55, 6607–6609 Search PubMed.
  173. Y. Okayasu, K. Wakabayashi and J. Yuasa, Inorg. Chem., 2022, 61, 15108–15115 Search PubMed.
  174. A. De Bettencourt-Dias, J. S. K. Rossini and J. A. Sobrinho, Dalton Trans., 2020, 49, 17699–17708 Search PubMed.
  175. J. Liu, W. Song, H. Niu, Y. Lu, H. Yang, W. Li, Y. Zhao and Z. Miao, Inorg. Chem., 2024, 63, 18429–18437 Search PubMed.
  176. J. Liu, Y. Zhang, R. Yao, H. Ren, W. Wang, H. Feng, W. Li and Z. Miao, Molecules, 2024, 29, 5887 Search PubMed.
  177. C. L. Liu, R. L. Zhang, C. S. Lin, L. P. Zhou, L. X. Cai, J. T. Kong, S. Q. Yang, K. L. Han and Q. F. Sun, J. Am. Chem. Soc., 2017, 139, 12474–12479 Search PubMed.
  178. D. M. Lyubov, A. N. Carneiro Neto, A. Fayoumi, K. A. Lyssenko, V. M. Korshunov, I. V. Taydakov, F. Salles, Y. Guari, J. Larionova, L. D. Carlos, J. Long and A. A. Trifonov, J. Mater. Chem. C, 2022, 10, 7176–7188 Search PubMed.
  179. A. Abhervé, M. Mastropasqua Talamo, N. Vanthuyne, F. Zinna, L. Di Bari, M. Grasser, B. Le Guennic and N. Avarvari, Eur. J. Inorg. Chem., 2022, e202200010 Search PubMed.
  180. H. Bolvin, A. Fürstenberg, B. Golesorkhi, H. Nozary, I. Taarit and C. Piguet, Acc. Chem. Res., 2022, 55, 442–456 Search PubMed.
  181. B. Golesorkhi, S. Naseri, L. Guénée, I. Taarit, F. Alves, H. Nozary and C. Piguet, J. Am. Chem. Soc., 2021, 143, 15326–15334 Search PubMed.
  182. I. Taarit, F. Alves, A. Benchohra, L. Guénée, B. Golesorkhi, A. Rosspeintner, A. Fürstenberg and C. Piguet, J. Am. Chem. Soc., 2023, 145, 8621–8633 Search PubMed.
  183. B. Golesorkhi, I. Taarit, H. Bolvin, H. Nozary, J. R. Jiménez, C. Besnard, L. Guénée, A. Fürstenberg and C. Piguet, Dalton Trans., 2021, 50, 7955–7968 Search PubMed.
  184. S. Naseri, I. Taarit, H. Bolvin, J. C. Bünzli, A. Fürstenberg, L. Guénée, G. Le-Hoang, M. Mirzakhani, H. Nozary, A. Rosspeintner and C. Piguet, Angew. Chem., Int. Ed., 2023, 62, e202314503 Search PubMed.
  185. K. Baudet, V. Kale, M. Mirzakhani, L. Babel, S. Naseri, C. Besnard, H. Nozary and C. Piguet, Inorg. Chem., 2020, 59, 62–75 Search PubMed.
  186. G. Le-Hoang, L. Guénée, S. Naseri, C. Besnard and C. Piguet, Helv. Chim. Acta, 2023, 106, e202200190 Search PubMed.
  187. S. Naseri, M. Mirzakhani, C. Besnard, L. Guénée, L. Briant, H. Nozary and C. Piguet, Chem. – Eur. J., 2023, 29, e202202727 Search PubMed.
  188. G. Le-Hoang, L. Guénée, Q. Sommer and C. Piguet, Inorg. Chem., 2024, 63, 3712–3723 Search PubMed.
  189. Y. Li, J. C. Huffman and A. H. Flood, Chem. Commun., 2007, 2692–2694 Search PubMed.
  190. A. Indapurkar, B. Henriksen, J. Tolman and J. Fletcher, J. Pharm. Sci., 2013, 102, 2589–2598 Search PubMed.
  191. R. M. Meudtner, M. Ostermeier, R. Goddard, C. Limberg and S. Hecht, Chem. – Eur. J., 2007, 13, 9834–9840 Search PubMed.
  192. J. P. Byrne, M. Martínez-Calvo, R. D. Peacock and T. Gunnlaugsson, Chem. – Eur. J., 2016, 22, 486–490 Search PubMed.
  193. I. N. Hegarty, C. S. Hawes and T. Gunnlaugsson, Org. Chem. Front., 2023, 10, 1915–1926 Search PubMed.
  194. N. Shukla, V. Singhmar, J. Sayala and A. K. Patra, Inorg. Chem., 2025, 64, 1287–1301 Search PubMed.
  195. F. Han, Q. Teng, Y. Zhang, Y. Wang and Q. Shen, Inorg. Chem., 2011, 50, 2634–2643 Search PubMed.
  196. K. Q. Mo, X. F. Ma, H. L. Wang, Z. H. Zhu, Y. C. Liu, H. H. Zou and F. P. Liang, Sci. Rep., 2019, 9, 12231 Search PubMed.
  197. C. Camp, V. Guidal, B. Biswas, J. Pécaut, L. Dubois and M. Mazzanti, Chem. Sci., 2012, 3, 2433–2448 Search PubMed.
  198. F. Lucio-Martínez, Z. Garda, B. Váradi, F. K. Kálmán, D. Esteban-Gómez, É. Tóth, G. Tircsó and C. Platas-Iglesias, Inorg. Chem., 2022, 61, 5157–5171 Search PubMed.
  199. M. Poncet, C. Besnard, J. R. Jiménez and C. Piguet, Inorg. Chem., 2024, 63, 18345–18354 Search PubMed.
  200. K. M. Ayers, N. D. Schley and G. Ung, Eur. J. Inorg. Chem., 2019, 3769–3775 Search PubMed.
  201. D. Schnable, K. Freedman, K. M. Ayers, N. D. Schley, M. Kol and G. Ung, Inorg. Chem., 2020, 59, 8498–8504 Search PubMed.
  202. K. M. Ayers, N. D. Schley and G. Ung, Inorg. Chem., 2020, 59, 7657–7665 Search PubMed.
  203. L. Arrico, C. De Rosa, L. Di Bari, A. Melchior and F. Piccinelli, Inorg. Chem., 2020, 59, 5050–5062 Search PubMed.
  204. M. Leonzio, A. Melchior, G. Faura, M. Tolazzi, F. Zinna, L. Di Bari and F. Piccinelli, Inorg. Chem., 2017, 56, 4413–4422 Search PubMed.
  205. M. Cui, A. L. Wang, C. L. Gao, L. Zhou, T. Wu, S. Fang, H. P. Xiao, F. C. Li and X. L. Li, Dalton Trans., 2021, 50, 1007–1018 Search PubMed.
  206. Y. Peng, T. Wang, C. Gao, F. Li and X. L. Li, CrystEngComm, 2024, 26, 3867–3873 Search PubMed.
  207. A. B. Solea, L. Yang, A. Crochet, K. M. Fromm, C. Allemann and O. Mamula, Chem, 2022, 4, 18–30 Search PubMed.
  208. O. Mamula, M. Lama, S. G. Telfer, A. Nakamura, R. Kuroda, H. Stoeckli-Evans and R. Scopelitti, Angew. Chem., Int. Ed., 2005, 44, 2527–2531 Search PubMed.
  209. A. Scrivanti, M. Bortoluzzi, A. Morandini, A. Dolmella, F. Enrichi, R. Mazzaro and A. Vomiero, New J. Chem., 2018, 42, 11064–11072 Search PubMed.
  210. K. R. Johnson, V. C. Lombardi and A. de Bettencourt-Dias, Chem. – Eur. J., 2020, 26, 12060–12066 Search PubMed.
  211. N. Souri, P. Tian, A. Lecointre, Z. Lemaire, S. Chafaa, J. M. Strub, S. Cianférani, M. Elhabiri, C. Platas-Iglesias and L. J. Charbonnière, Inorg. Chem., 2016, 55, 12962–12974 Search PubMed.
  212. N. Souri, P. Tian, C. Platas-Iglesias, K. L. Wong, A. Nonat and L. J. Charbonnière, J. Am. Chem. Soc., 2017, 139, 1456–1459 Search PubMed.
  213. R. C. Knighton, L. K. Soro, W. Thor, J. M. Strub, S. Cianférani, Y. Mély, M. Lenertz, K. L. Wong, C. Platas-Iglesias, F. Przybilla and L. J. Charbonnière, J. Am. Chem. Soc., 2022, 144, 13356–13365 Search PubMed.
  214. L. Petitpoisson, A. Mahamoud, V. Mazan, M. Sy, O. Jeannin, E. Tóth, L. J. Charbonnière, M. Elhabiri and A. M. Nonat, Inorg. Chem., 2024, 63, 22829–22844 Search PubMed.
  215. W. Chen, X. Tang, W. Dou, B. Wang, L. Guo, Z. Ju and W. Liu, Chem. – Eur. J., 2017, 23, 9804–9811 Search PubMed.
  216. Y. Yao, Y. Zhou, T. Zhu, T. Gao, H. Li and P. Yan, ACS Appl. Mater. Interfaces, 2020, 12, 15338–15347 Search PubMed.
  217. J. J. Pang, Z. Q. Yao, K. Zhang, Q. W. Li, Z. X. Fu, R. Zheng, W. Li, J. Xu and X. H. Bu, Angew. Chem., Int. Ed., 2023, 62, e202217456 Search PubMed.
  218. R. Sanchez-Fernandez, I. Obregon-Gomez, A. Sarmiento, M. E. Vazquez and E. Pazos, Chem. Commun., 2024, 60, 12650 Search PubMed.
  219. O. Kotova, S. Comby, C. Lincheneau and T. Gunnlaugsson, Chem. Sci., 2017, 8, 3419–3426 Search PubMed.
  220. X. Q. Guo, L. P. Zhou, S. J. Hu, L. X. Cai, P. M. Cheng and Q. F. Sun, J. Am. Chem. Soc., 2021, 143, 6202–6210 Search PubMed.
  221. W. W. Qin, Y. L. Li, Z. H. Zhu, F. P. Liang, Q. Hu and H. H. Zou, Inorg. Chem. Front., 2023, 10, 6269–6281 Search PubMed.
  222. Y. Zhang, B. Ali, J. Wu, M. Guo, Y. Yu, Z. Liu and J. Tang, Inorg. Chem., 2019, 58, 3167–3174 Search PubMed.
  223. T.-T. Wang, H. Wang and W.-B. Sun, Inorg. Chem. Front., 2025, 12, 1918 Search PubMed.
  224. X. L. Li, L. Zhao, J. Wu, W. Shi, N. Struch, A. Lützen, A. K. Powell, P. Cheng and J. Tang, Chem. Sci., 2022, 13, 10048–10056 Search PubMed.
  225. J. X. Liu, K. Chen and C. Redshaw, Chem. Soc. Rev., 2023, 52, 1428–1455 Search PubMed.
  226. Y. L. Li, H. L. Wang, Z. H. Zhu, F. P. Liang and H. H. Zou, Coord. Chem. Rev., 2023, 493, 215322 Search PubMed.
  227. K. H. Yim, C. T. Yeung, H. Y. Wong and G. L. Law, Inorg. Chem. Front., 2021, 8, 2952 Search PubMed.
  228. L. Hu, Y. Yang, Y. Gao, Y. Wei, J. Zhu and W. Wu, Chem. Eng. J., 2024, 488, 150965 Search PubMed.
  229. J. M. Lehn, A. Rigault, J. Siegel, J. Harrowfield, B. Chevrier and D. Moras, Proc. Natl. Acad. Sci. U. S. A., 1987, 84, 2565–2569 Search PubMed.
  230. C. Piguet, G. Bernardinelli and G. Hopfgartner, Chem. Rev., 1997, 97, 2005–2062 Search PubMed.
  231. O. Kotova, S. Comby, K. Pandurangan, F. Stomeo, J. E. O’Brien, M. Feeney, R. D. Peacock, C. P. McCoy and T. Gunnlaugsson, Dalton Trans., 2018, 47, 12308–12317 Search PubMed.
  232. C. L. Liu, L. P. Zhou, D. Tripathy and Q. F. Sun, Chem. Commun., 2017, 53, 2459–2462 Search PubMed.
  233. M. Albrecht and S. Kotila, Angew. Chem., Int. Ed. Engl., 1995, 34, 4–7 Search PubMed.
  234. K. H. Yim, C. T. Yeung, M. R. Probert, W. T. K. Chan, L. E. Mackenzie, R. Pal, W. T. Wong and G. L. Law, Commun. Chem., 2021, 4, 116 Search PubMed.
  235. S. Comby, F. Stomeo, C. P. Mccoy and T. Gunnlaugsson, Helv. Chim. Acta, 2009, 92, 2461–2473 Search PubMed.
  236. F. Stomeo, C. Lincheneau, J. P. Leonard, J. E. O. Brien, R. D. Peacock, C. P. Mccoy and T. Gunnlaugsson, J. Am. Chem. Soc., 2009, 131, 9636–9637 Search PubMed.
  237. C. Lincheneau, R. D. Peacock and T. Gunnlaugsson, Chem. – Asian J., 2010, 5, 500–504 Search PubMed.
  238. D. E. Barry, J. A. Kitchen, K. Pandurangan, A. J. Savyasachi, R. D. Peacock and T. Gunnlaugsson, Inorg. Chem., 2020, 59, 2646–2650 Search PubMed.
  239. I. N. Hegarty, D. E. Barry, J. P. Byrne, O. Kotova and T. Gunnlaugsson, Chem. Commun., 2023, 59, 6044–6047 Search PubMed.
  240. D. E. Barry, O. Kotova, N. A. O’Shea, S. R. Donohoe, A. J. Savyasachi and T. Gunnlaugsson, Mater. Chem. Front., 2025, 9(2), 258–270 Search PubMed.
  241. J. Zhang, Y. Zhou, Y. Yao, Z. Cheng, T. Gao, H. Li and P. Yan, J. Mater. Chem. C, 2020, 8, 6788–6796 Search PubMed.
  242. L. X. Cai, L. L. Yan, S. C. Li, L. P. Zhou and Q. F. Sun, Dalton Trans., 2018, 47, 14204–14210 Search PubMed.
  243. R. Chen, Q. Q. Yan, S. J. Hu, X. Q. Guo, L. X. Cai, D. N. Yan, L. P. Zhou and Q. F. Sun, Org. Chem. Front., 2021, 8, 2576–2582 Search PubMed.
  244. R. Chen, Q. Q. Yan, S. J. Hu, X. Q. Guo, L. P. Zhou and Q. F. Sun, Dalton Trans., 2022, 52, 37–43 Search PubMed.
  245. X. Guo, X. Zhang, S. Hu, L. Zhou and Q. Sun, Chem. Res. Chin. Univ., 2024, 40, 842–848 Search PubMed.
  246. B. Golesorkhi, L. Guénée, H. Nozary, A. Fürstenberg, Y. Suffren, S. V. Eliseeva, S. Petoud, A. Hauser and C. Piguet, Chem. – Eur. J., 2018, 24, 13158–13169 Search PubMed.
  247. C. Egger, L. Guénée, N. Deorukhkar and C. Piguet, Dalton Trans., 2024, 53, 6050–6062 Search PubMed.
  248. D. Zare, Y. Suffren, H. Nozary, A. Hauser and C. Piguet, Angew. Chem., Int. Ed., 2017, 56, 14612–14617 Search PubMed.
  249. N. Deorukhkar, C. Egger, L. Guénée, C. Besnard and C. Piguet, J. Am. Chem. Soc., 2024, 146, 308–318 Search PubMed.
  250. T. Lathion, A. Fürstenberg, C. Besnard, A. Hauser, A. Bousseksou and C. Piguet, Inorg. Chem., 2020, 59, 1091–1103 Search PubMed.
  251. T. Lathion, N. Deorukhkar, C. Egger, H. Nozary and C. Piguet, Dalton Trans., 2024, 53, 17731–18056 Search PubMed.
  252. D. J. Bell, T. Zhang, N. Geue, C. J. Rogers, P. E. Barran, A. M. Bowen, L. S. Natrajan and I. A. Riddell, Chem. – Eur. J., 2023, 29, e202302497 Search PubMed.
  253. D. J. Bell, L. S. Natrajan and I. A. Riddell, Coord. Chem. Rev., 2022, 472, 214786 Search PubMed.
  254. E. G. Percástegui, Eur. J. Inorg. Chem., 2021, 4425–4438 Search PubMed.
  255. F. Guo, D. F. Li, F. Gao, K. Xu, J. Zhang, X. G. Yi, D. P. Li and Y. X. Li, Inorg. Chem., 2022, 61, 17089–17100 Search PubMed.
  256. J. Li, M. Kou, S. Zhou, F. Dong, X. Huang, X. Tang, Y. Tang and W. Liu, Nat. Commun., 2025, 16, 2169 Search PubMed.
  257. S. M. Jansze, G. Cecot, M. D. Wise, K. O. Zhurov, T. K. Ronson, A. M. Castilla, A. Finelli, P. Pattison, E. Solari, R. Scopelliti, G. E. Zelinskii, A. V. Vologzhanina, Y. Z. Voloshin, J. R. Nitschke and K. Severin, J. Am. Chem. Soc., 2016, 138, 2046–2054 Search PubMed.
  258. J. Su, F. Yin, X. F. Duan, J. Y. Zhou, L. P. Zhou, C. Bin Tian and Q. F. Sun, Inorg. Chem. Front., 2025, 12, 3073–3082 Search PubMed.
  259. X. Q. Guo, P. Yu, L. P. Zhou, S. J. Hu, X. F. Duan, L. X. Cai, L. Bao, X. Lu and Q. F. Sun, Nat. Synth., 2025, 4, 359–369 Search PubMed.
  260. X. Z. Li, L. P. Zhou, L. L. Yan, D. Q. Yuan, C. S. Lin and Q. F. Sun, J. Am. Chem. Soc., 2017, 139, 8237–8244 Search PubMed.
  261. Z. Wang, L. He, B. Liu, L. P. Zhou, L. X. Cai, S. J. Hu, X. Z. Li, Z. Li, T. Chen, X. Li and Q. F. Sun, J. Am. Chem. Soc., 2020, 142, 16409–16419 Search PubMed.
  262. Q. Y. Zhu, L. P. Zhou, L. X. Cai, S. J. Hu, X. Z. Li and Q. F. Sun, Inorg. Chem., 2022, 61, 16814–16821 Search PubMed.
  263. X. Q. Guo, L. P. Zhou, S. J. Hu and Q. F. Sun, Dalton Trans., 2024, 53, 4772–4780 Search PubMed.
  264. X.-F. Duan, H. Ji, L.-P. Zhou, S.-J. Hu, J. Fu, P. Duan, X.-Q. Guo and Q.-F. Sun, CCS Chem., 2025, 1–9 Search PubMed.
  265. C. T. Yeung, K. H. Yim, H. Y. Wong, R. Pal, W. S. Lo, S. C. Yan, M. Yee-Man Wong, D. Yufit, D. E. Smiles, L. J. McCormick, S. J. Teat, D. K. Shuh, W. T. Wong and G. L. Law, Nat. Commun., 2017, 8, 1128 Search PubMed.
  266. C. T. Yeung, W. T. K. Chan, S. C. Yan, K. L. Yu, K. H. Yim, W. T. Wong and G. L. Law, Chem. Commun., 2015, 51, 592–595 Search PubMed.
  267. K.-H. Yim, C.-T. Yeung, M. Y.-M. Wong, M. R. Probert and G.-L. Law, Chem. – Eur. J., 2022, 28, e202201655 Search PubMed.
  268. C. L. Liu, R. L. Zhang, C. S. Lin, L. P. Zhou, L. X. Cai, J. T. Kong, S. Q. Yang, K. L. Han and Q. F. Sun, J. Am. Chem. Soc., 2017, 139, 12474–12479 Search PubMed.
  269. X. Q. Guo, L. P. Zhou, L. X. Cai and Q. F. Sun, Chem. – Eur. J., 2018, 24, 6936–6940 Search PubMed.
  270. S. J. Hu, X. Q. Guo, L. P. Zhou, L. X. Cai and Q. F. Sun, Chin. J. Chem., 2019, 37, 657–662 Search PubMed.
  271. S. Y. Wu, X. Q. Guo, L. P. Zhou and Q. F. Sun, Inorg. Chem., 2019, 58, 7091–7098 Search PubMed.
  272. S. J. Hu, X. Q. Guo, L. P. Zhou, L. X. Cai, C. Bin Tian and Q. F. Sun, Chin. J. Chem., 2023, 41, 797–804 Search PubMed.
  273. Z. Zhu, S. Hu, Z. Liu, L. Zhou, C. Tian and Q. Sun, Chin. Chem. Lett., 2024, 36, 109641 Search PubMed.
  274. Y. Zhou, F. Yin, S. J. Hu, L. P. Zhou, J. Yang and Q. F. Sun, Inorg. Chem., 2025, 64, 6927–6934 Search PubMed.
  275. N. Klangwart, C. Ruijs, C. S. Hawes, T. Gunnlaugsson and O. Kotova, Supramol. Chem., 2022, 34, 10–19 Search PubMed.
  276. L. P. Zhou, X. S. Feng, S. J. Hu and Q. F. Sun, J. Am. Chem. Soc., 2023, 145, 17845–17855 Search PubMed.
  277. T. Zhao, Y. F. Zhang, G. H. Wang, X. X. Wang, P. F. Feng and S. Q. Zang, Angew. Chem., Int. Ed., 2025, e202421426 Search PubMed.
  278. J. F. Stoddart,Mechanically Interlocked Molecules (MIMs) – Molecular Shuttles, Switches, and Machines, Weinheim, Germany, 1998 Search PubMed.
  279. C. J. Bruns and J. Fraser Stoddart, The Nature of the Mechanical Bond: From Molecules to Machines, John Wiley & Sons, 1st edn, 2017, pp. 4–54 Search PubMed.
  280. N. H. Evans, ChemPlusChem, 2020, 85, 783–792 Search PubMed.
  281. A. Savoini, P. R. Gallagher, A. Saady and S. M. Goldup, J. Am. Chem. Soc., 2024, 146, 8472–8479 Search PubMed.
  282. S. M. Goldup, Acc. Chem. Res., 2024, 57, 1696–1708 Search PubMed.
  283. J. E. M. Lewis, P. D. Beer, S. J. Loeb and S. M. Goldup, Chem. Soc. Rev., 2017, 46, 2577–2591 Search PubMed.
  284. A. Saura-Sanmartin, A. Pastor, A. Martinez-Cuezva, G. Cutillas-Font, M. Alajarin and J. Berna, Chem. Soc. Rev., 2022, 51, 4949–4976 Search PubMed.
  285. T. G. Johnson and M. J. Langton, J. Am. Chem. Soc., 2023, 145, 27167–27184 Search PubMed.
  286. M. Nandi, S. Bej, T. Jana and P. Ghosh, Chem. Commun., 2023, 59, 14776–14790 Search PubMed.
  287. S. Mena-Hernando and E. M. Pérez, Chem. Soc. Rev., 2019, 48, 5016–5032 Search PubMed.
  288. C. Lincheneau, B. Jean-Denis and T. Gunnlaugsson, Chem. Commun., 2014, 50, 2857–2860 Search PubMed.
  289. M. Nandi, S. Bej, T. K. Ghosh and P. Ghosh, Chem. Commun., 2019, 55, 3085–3088 Search PubMed.
  290. Y. A. Mondjinou, B. P. Loren, C. J. Collins, S. H. Hyun, A. Demoret, J. Skulsky, C. Chaplain, V. Badwaik and D. H. Thompson, Bioconjugate Chem., 2018, 29, 3550–3560 Search PubMed.
  291. D. A. Leigh, L. Pirvu, F. Schaufelberger, D. J. Tetlow and L. Zhang, Angew. Chem., Int. Ed., 2018, 57, 10484–10488 Search PubMed.
  292. A. Ramström, D. R. S. Pooler, H. Abasov, M. Tomar, S. Crespi and F. Schaufelberger, Angew. Chem., Int. Ed., 2025, 64, e202505666 Search PubMed.
  293. Q. Zhou, X. Dong, G. Chi, X. Y. Cao, N. Zhang, S. Wu, Y. Ma, Z. H. Zhang and L. Zhang, J. Am. Chem. Soc., 2024, 146, 22405–22412 Search PubMed.
  294. L. Zhang, A. J. Stephens, A. L. Nussbaumer, J. F. Lemonnier, P. Jurček, I. J. Vitorica-Yrezabal and D. A. Leigh, Nat. Chem., 2018, 10, 1083–1088 Search PubMed.
  295. D. A. Leigh, J. J. Danon, S. D. P. Fielden, J. F. Lemonnier, G. F. S. Whitehead and S. L. Woltering, Nat. Chem., 2021, 13, 117–122 Search PubMed.
  296. J. J. Danon, A. Krüger, D. A. Leigh, J.-F. Lemonnier, A. J. Stephens, I. J. Vitorica-Yrezabal and S. L. Woltering, Science, 2017, 355, 159–162 Search PubMed.
  297. M. Calvaresi, A. S. Duwez, D. A. Leigh, D. Sluysmans, Y. Song, F. Zerbetto and L. Zhang, Chem, 2023, 9, 65–75 Search PubMed.
  298. D. A. Leigh, L. Pirvu and F. Schaufelberger, J. Am. Chem. Soc., 2019, 141, 6054–6059 Search PubMed.
  299. N. Katsonis, F. Lancia, D. A. Leigh, L. Pirvu, A. Ryabchun and F. Schaufelberger, Nat. Chem., 2020, 12, 939–944 Search PubMed.
  300. Z. Ashbridge, E. Kreidt, L. Pirvu, F. Schaufelberger, J. H. Stenlid, F. Abild-Pedersen and D. A. Leigh, Science, 2022, 375, 1035–1044 Search PubMed.
  301. Z. Ashbridge, O. M. Knapp, E. Kreidt, D. A. Leigh, L. Pirvu and F. Schaufelberger, J. Am. Chem. Soc., 2022, 144, 17232–17240 Search PubMed.
  302. O. Kotova, S. J. Bradberry, A. J. Savyasachi and T. Gunnlaugsson, Dalton Trans., 2018, 47, 16377–16387 Search PubMed.
  303. R. Laishram, S. Sarkar, U. Maitra and S. J. George, J. Mater. Chem. C, 2024, 12, 15418–15422 Search PubMed.
  304. R. A. Tigaa, X. Aerken, A. Fuchs and A. de Bettencourt-Dias, Eur. J. Inorg. Chem., 2017, 5310–5317 Search PubMed.
  305. S. Lim, Y. Cho, J. H. Kang, M. Hwang, Y. Park, S. K. Kwak, S. H. Jung and J. H. Jung, J. Am. Chem. Soc., 2024, 146, 18484–18497 Search PubMed.
  306. Y. Liang, P. Zhao, Z. Yan, Q. Zhang, Y. Liu and R. Zhang, Macromolecules, 2025, 58, 149–157 Search PubMed.
  307. G. Le-Hoang, L. Guénée, M. Bertrand-Avebe, L. Babel, A. Rosspeintner and C. Piguet, Inorg. Chem., 2025, 64, 3941–3958 Search PubMed.
  308. I. N. Hegarty, S. J. Bradberry, J. I. Lovitt, J. M. Delente, N. Willis-Fox, R. Daly and T. Gunnlaugsson, Mater. Chem. Front., 2023, 7, 906–916 Search PubMed.
  309. I. N. Hegarty, A. F. Henwood, S. J. Bradberry and T. Gunnlaugsson, Org. Biomol. Chem., 2023, 21, 1549–1557 Search PubMed.
  310. S. J. Bradberry, G. Dee, O. Kotova, C. P. McCoy and T. Gunnlaugsson, Chem. Commun., 2019, 55, 1754–1757 Search PubMed.
  311. O. Kotova, C. O’Reilly, S. T. Barwich, L. E. Mackenzie, A. D. Lynes, A. J. Savyasachi, M. Ruether, R. Pal, M. E. Möbius and T. Gunnlaugsson, Chem, 2022, 8, 1395–1414 Search PubMed.
  312. A. J. Savyasachi, O. Kotova, E. T. Luis, A. D. Lynes, S. Mills, S. A. Bright, G. J. McManus, M. E. Möbius, D. C. Williams, R. Pal, J. J. Boland and T. Gunnlaugsson, Chem, 2024, 11, 102321 Search PubMed.
  313. T. A. Gudmundsson, O. Kotova, S. Barwich, M. E. Möbius and T. Gunnlaugsson, Chem. – Eur. J., 2025, 31, e202403919 Search PubMed.
  314. J. M. Delente, O. Kotova, N. Willis-Fox, J. E. O’Brien, B. Twamley, R. Daly and T. Gunnlaugsson, Adv. Opt. Mater., 2025, 13, 2402714 Search PubMed.
  315. S. Liao, Z. Li, L. Ren, T. Lin, C. Lin, C. Zhao, M. Gao and X. Wu, ACS Appl. Polym. Mater., 2025, 7, 700–709 Search PubMed.
  316. N. C. Martinez-Gomez, H. N. Vu and E. Skovran, Inorg. Chem., 2016, 55, 10083–10089 Search PubMed.
  317. A. M. Zytnick, S. M. Gutenthaler-Tietze, A. T. Aron, Z. L. Reitz, M. T. Phi, N. M. Good, D. Petras, L. J. Daumann and N. C. Martinez-Gomez, Proc. Natl. Acad. Sci. U. S. A., 2024, 121, e2322096121 Search PubMed.
  318. B. Yu, Z. H. Zhu, W. W. Qin, H. L. Wang, Y. L. Li, F. P. Liang and H. H. Zou, ACS Mater. Lett., 2024, 6, 3312–3326 Search PubMed.
  319. R. M. Pallares, Y. Li and R. J. Abergel, TrAC, Trends Anal. Chem., 2023, 167, 117251 Search PubMed.
  320. R. M. Pallares, D. D. An, P. Tewari, E. T. Wang and R. J. Abergel, ACS Sens., 2020, 5, 1281–1286 Search PubMed.
  321. R. M. Pallares and R. J. Abergel, Toxicology, 2024, 509, 153967 Search PubMed.
  322. R. M. Pallares, S. Hébert, M. Sturzbecher-Hoehne and R. J. Abergel, New J. Chem., 2021, 45, 14364–14368 Search PubMed.
  323. E. J. Werner and S. M. Biros, Org. Chem. Front., 2019, 6, 2067–2094 Search PubMed.
  324. M. Gut, T. Wilhelm, O. Beniston, S. Ogundipe, C. C. Kuo, K. Nguyen and A. Furst, Adv. Mater., 2025, 37, 2412607 Search PubMed.
  325. R. M. Pallares, M. Charrier, S. Tejedor-Sanz, D. Li, P. D. Ashby, C. M. Ajo-Franklin, C. Y. Ralston and R. J. Abergel, J. Am. Chem. Soc., 2022, 144, 854–861 Search PubMed.
  326. X. Z. Li, L. P. Zhou, L. L. Yan, Y. M. Dong, Z. L. Bai, X. Q. Sun, J. Diwu, S. Wang, J. C. Bünzli and Q. F. Sun, Nat. Commun., 2018, 9, 547 Search PubMed.
  327. H. Lumpe, A. Menke, C. Haisch, P. Mayer, A. Kabelitz, K. V. Yusenko, A. Guilherme Buzanich, T. Block, R. Pöttgen, F. Emmerling and L. J. Daumann, Chem. – Eur. J., 2020, 26, 10133–10139 Search PubMed.
  328. M. V. Evsiunina, E. K. Khult, P. I. Matveev, P. Kalle, P. S. Lemport, V. S. Petrov, S. A. Aksenova, Y. V. Nelyubina, D. S. Koshelev, V. V. Utochnikova, V. G. Petrov, Y. A. Ustynyuk and V. G. Nenajdenko, Sep. Purif. Technol., 2024, 339, 126621 Search PubMed.
  329. S. Pramanik, S. Kaur, I. Popovs, A. S. Ivanov and S. Jansone-Popova, Eur. J. Inorg. Chem., 2024, e202400064 Search PubMed.
  330. T. Liu, K. R. Johnson, S. Jansone-Popova and D. E. Jiang, JACS Au, 2022, 2, 1428–1434 Search PubMed.
  331. K. R. Johnson, D. M. Driscoll, J. T. Damron, A. S. Ivanov and S. Jansone-Popova, JACS Au, 2023, 3, 584–591 Search PubMed.
  332. S. Pramanik, B. Li, D. M. Driscoll, K. R. Johnson, B. R. Evans, J. T. Damron, A. S. Ivanov, D. E. Jiang, J. Einkauf, I. Popovs and S. Jansone-Popova, J. Am. Chem. Soc., 2024, 146, 25669–25679 Search PubMed.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.